CN113929697A - 1,3, 4-oxadiazole psoralen derivatives and preparation method and application thereof - Google Patents
1,3, 4-oxadiazole psoralen derivatives and preparation method and application thereof Download PDFInfo
- Publication number
- CN113929697A CN113929697A CN202111351143.3A CN202111351143A CN113929697A CN 113929697 A CN113929697 A CN 113929697A CN 202111351143 A CN202111351143 A CN 202111351143A CN 113929697 A CN113929697 A CN 113929697A
- Authority
- CN
- China
- Prior art keywords
- compound
- oxadiazole
- reaction
- preparation
- reduced pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 1,3, 4-oxadiazole psoralen derivatives Chemical class 0.000 title claims abstract description 156
- 238000002360 preparation method Methods 0.000 title claims abstract description 48
- 150000001875 compounds Chemical class 0.000 claims abstract description 129
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 35
- 230000000895 acaricidal effect Effects 0.000 claims abstract description 24
- 241000700605 Viruses Species 0.000 claims abstract description 22
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 22
- 239000003899 bactericide agent Substances 0.000 claims abstract description 17
- 239000012752 auxiliary agent Substances 0.000 claims abstract description 6
- 238000010189 synthetic method Methods 0.000 claims abstract 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 99
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 96
- 239000000203 mixture Substances 0.000 claims description 93
- 238000006243 chemical reaction Methods 0.000 claims description 91
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 60
- FKASFBLJDCHBNZ-UHFFFAOYSA-N 1,3,4-oxadiazole Chemical compound C1=NN=CO1 FKASFBLJDCHBNZ-UHFFFAOYSA-N 0.000 claims description 58
- DWAOUXYZOSPAOH-UHFFFAOYSA-N 4-[2-(diethylamino)ethoxy]furo[3,2-g]chromen-7-one;hydrochloride Chemical compound [Cl-].O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC[NH+](CC)CC DWAOUXYZOSPAOH-UHFFFAOYSA-N 0.000 claims description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 45
- 238000003756 stirring Methods 0.000 claims description 41
- 239000007788 liquid Substances 0.000 claims description 38
- 239000007787 solid Substances 0.000 claims description 32
- 239000002904 solvent Substances 0.000 claims description 29
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 28
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 28
- 238000004440 column chromatography Methods 0.000 claims description 28
- 239000000706 filtrate Substances 0.000 claims description 28
- 239000012074 organic phase Substances 0.000 claims description 28
- 238000001035 drying Methods 0.000 claims description 26
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 24
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 21
- 238000005406 washing Methods 0.000 claims description 21
- 238000000967 suction filtration Methods 0.000 claims description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 16
- 238000010992 reflux Methods 0.000 claims description 16
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 15
- 229940126214 compound 3 Drugs 0.000 claims description 14
- 229940125898 compound 5 Drugs 0.000 claims description 14
- 239000004480 active ingredient Substances 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 13
- 230000000749 insecticidal effect Effects 0.000 claims description 13
- 238000000746 purification Methods 0.000 claims description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 12
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 12
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical group C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 claims description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 125000006483 4-iodobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1I)C([H])([H])* 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 4
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 claims description 4
- 125000000173 4-trifluoromethoxy benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC(F)(F)F)C([H])([H])* 0.000 claims description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 4
- 239000011609 ammonium molybdate Substances 0.000 claims description 4
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 claims description 4
- 235000018660 ammonium molybdate Nutrition 0.000 claims description 4
- 229940010552 ammonium molybdate Drugs 0.000 claims description 4
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 4
- 235000019441 ethanol Nutrition 0.000 claims description 4
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 239000005457 ice water Substances 0.000 claims description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical class [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 claims description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 3
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 claims description 3
- 125000006279 3-bromobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(Br)=C1[H])C([H])([H])* 0.000 claims description 3
- 125000006180 3-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1[H])C([H])([H])[H])C([H])([H])* 0.000 claims description 3
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 claims description 3
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 claims description 3
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 claims description 3
- 125000003352 4-tert-butyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 3
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 claims description 2
- 229940125904 compound 1 Drugs 0.000 claims description 2
- 229940125782 compound 2 Drugs 0.000 claims description 2
- 239000000417 fungicide Substances 0.000 claims description 2
- 238000003828 vacuum filtration Methods 0.000 claims description 2
- 230000000855 fungicidal effect Effects 0.000 claims 2
- VEUMBMHMMCOFAG-UHFFFAOYSA-N 2,3-dihydrooxadiazole Chemical compound N1NC=CO1 VEUMBMHMMCOFAG-UHFFFAOYSA-N 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 241000607479 Yersinia pestis Species 0.000 abstract description 20
- 201000010099 disease Diseases 0.000 abstract description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 16
- 241000238631 Hexapoda Species 0.000 abstract description 14
- 239000002917 insecticide Substances 0.000 abstract description 14
- 239000000642 acaricide Substances 0.000 abstract description 13
- 239000000126 substance Substances 0.000 abstract description 2
- 238000010413 gardening Methods 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 description 56
- 241000196324 Embryophyta Species 0.000 description 47
- 239000000243 solution Substances 0.000 description 39
- 240000007594 Oryza sativa Species 0.000 description 35
- 241001249129 Scirpophaga incertulas Species 0.000 description 30
- 235000007164 Oryza sativa Nutrition 0.000 description 29
- 235000009566 rice Nutrition 0.000 description 29
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 27
- 235000021307 Triticum Nutrition 0.000 description 24
- 241000209140 Triticum Species 0.000 description 24
- 239000003814 drug Substances 0.000 description 24
- 239000000839 emulsion Substances 0.000 description 24
- 238000009472 formulation Methods 0.000 description 24
- 239000000575 pesticide Substances 0.000 description 21
- 244000241257 Cucumis melo Species 0.000 description 18
- 239000000843 powder Substances 0.000 description 18
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 16
- 241000219173 Carica Species 0.000 description 16
- 235000009467 Carica papaya Nutrition 0.000 description 16
- 235000021536 Sugar beet Nutrition 0.000 description 16
- UFEODZBUAFNAEU-NLRVBDNBSA-N fluoxastrobin Chemical compound C=1C=CC=C(OC=2C(=C(OC=3C(=CC=CC=3)Cl)N=CN=2)F)C=1C(=N/OC)\C1=NOCCO1 UFEODZBUAFNAEU-NLRVBDNBSA-N 0.000 description 16
- 239000008187 granular material Substances 0.000 description 16
- 239000003921 oil Substances 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- 239000005784 Fluoxastrobin Substances 0.000 description 14
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 14
- 241000220225 Malus Species 0.000 description 14
- 235000011430 Malus pumila Nutrition 0.000 description 14
- 235000015103 Malus silvestris Nutrition 0.000 description 14
- 240000003768 Solanum lycopersicum Species 0.000 description 14
- 239000003480 eluent Substances 0.000 description 14
- 239000012044 organic layer Substances 0.000 description 14
- 240000008067 Cucumis sativus Species 0.000 description 13
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 13
- 241000208125 Nicotiana Species 0.000 description 13
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 13
- 230000000840 anti-viral effect Effects 0.000 description 13
- 238000001914 filtration Methods 0.000 description 13
- 230000005764 inhibitory process Effects 0.000 description 13
- 235000017060 Arachis glabrata Nutrition 0.000 description 12
- 244000105624 Arachis hypogaea Species 0.000 description 12
- 235000010777 Arachis hypogaea Nutrition 0.000 description 12
- 235000018262 Arachis monticola Nutrition 0.000 description 12
- 229920000742 Cotton Polymers 0.000 description 12
- 241000371652 Curvularia clavata Species 0.000 description 12
- 241000219146 Gossypium Species 0.000 description 12
- 241000220259 Raphanus Species 0.000 description 12
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 12
- 240000008042 Zea mays Species 0.000 description 12
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 12
- 235000020971 citrus fruits Nutrition 0.000 description 12
- 235000020232 peanut Nutrition 0.000 description 12
- 241000238876 Acari Species 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 235000002566 Capsicum Nutrition 0.000 description 10
- 241000207199 Citrus Species 0.000 description 10
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 10
- 244000017020 Ipomoea batatas Species 0.000 description 10
- 235000002678 Ipomoea batatas Nutrition 0.000 description 10
- 240000005561 Musa balbisiana Species 0.000 description 10
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 10
- 241001477931 Mythimna unipuncta Species 0.000 description 10
- 239000006002 Pepper Substances 0.000 description 10
- 244000046052 Phaseolus vulgaris Species 0.000 description 10
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 10
- 235000016761 Piper aduncum Nutrition 0.000 description 10
- 240000003889 Piper guineense Species 0.000 description 10
- 235000017804 Piper guineense Nutrition 0.000 description 10
- 235000008184 Piper nigrum Nutrition 0.000 description 10
- 240000000111 Saccharum officinarum Species 0.000 description 10
- 235000007201 Saccharum officinarum Nutrition 0.000 description 10
- 244000062793 Sorghum vulgare Species 0.000 description 10
- 240000004922 Vigna radiata Species 0.000 description 10
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 10
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 10
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 10
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 10
- 235000005822 corn Nutrition 0.000 description 10
- 238000012544 monitoring process Methods 0.000 description 10
- 239000002435 venom Substances 0.000 description 10
- 210000001048 venom Anatomy 0.000 description 10
- 231100000611 venom Toxicity 0.000 description 10
- 230000004071 biological effect Effects 0.000 description 9
- NCVWJDISIZHFQS-CQSZACIVSA-N (-)-antofine Chemical compound C12=CC(OC)=C(OC)C=C2C2=CC(OC)=CC=C2C2=C1C[C@H]1CCCN1C2 NCVWJDISIZHFQS-CQSZACIVSA-N 0.000 description 8
- ZZLCFHIKESPLTH-UHFFFAOYSA-N 4-Methylbiphenyl Chemical compound C1=CC(C)=CC=C1C1=CC=CC=C1 ZZLCFHIKESPLTH-UHFFFAOYSA-N 0.000 description 8
- 239000005660 Abamectin Substances 0.000 description 8
- 244000198134 Agave sisalana Species 0.000 description 8
- 244000291564 Allium cepa Species 0.000 description 8
- 235000010167 Allium cepa var aggregatum Nutrition 0.000 description 8
- 240000002234 Allium sativum Species 0.000 description 8
- 244000144730 Amygdalus persica Species 0.000 description 8
- 240000007087 Apium graveolens Species 0.000 description 8
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 8
- 235000010591 Appio Nutrition 0.000 description 8
- 235000007319 Avena orientalis Nutrition 0.000 description 8
- 244000075850 Avena orientalis Species 0.000 description 8
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 8
- 235000017491 Bambusa tulda Nutrition 0.000 description 8
- 241000255789 Bombyx mori Species 0.000 description 8
- 241000219198 Brassica Species 0.000 description 8
- 235000003351 Brassica cretica Nutrition 0.000 description 8
- 240000007124 Brassica oleracea Species 0.000 description 8
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 8
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 8
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 8
- 235000003343 Brassica rupestris Nutrition 0.000 description 8
- 235000002568 Capsicum frutescens Nutrition 0.000 description 8
- 241000219109 Citrullus Species 0.000 description 8
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 8
- 235000013162 Cocos nucifera Nutrition 0.000 description 8
- 244000060011 Cocos nucifera Species 0.000 description 8
- 240000007154 Coffea arabica Species 0.000 description 8
- 235000009847 Cucumis melo var cantalupensis Nutrition 0.000 description 8
- 235000001950 Elaeis guineensis Nutrition 0.000 description 8
- 244000127993 Elaeis melanococca Species 0.000 description 8
- 241000605372 Fritillaria Species 0.000 description 8
- 235000010469 Glycine max Nutrition 0.000 description 8
- 244000068988 Glycine max Species 0.000 description 8
- 244000020551 Helianthus annuus Species 0.000 description 8
- 235000003222 Helianthus annuus Nutrition 0.000 description 8
- 240000005979 Hordeum vulgare Species 0.000 description 8
- 235000007340 Hordeum vulgare Nutrition 0.000 description 8
- 235000008694 Humulus lupulus Nutrition 0.000 description 8
- 244000025221 Humulus lupulus Species 0.000 description 8
- 240000003183 Manihot esculenta Species 0.000 description 8
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 8
- 241000233855 Orchidaceae Species 0.000 description 8
- 240000004371 Panax ginseng Species 0.000 description 8
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 8
- 235000003140 Panax quinquefolius Nutrition 0.000 description 8
- 244000082204 Phyllostachys viridis Species 0.000 description 8
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 8
- 235000010582 Pisum sativum Nutrition 0.000 description 8
- 240000004713 Pisum sativum Species 0.000 description 8
- 235000006040 Prunus persica var persica Nutrition 0.000 description 8
- 239000005663 Pyridaben Substances 0.000 description 8
- 235000003434 Sesamum indicum Nutrition 0.000 description 8
- 244000040738 Sesamum orientale Species 0.000 description 8
- 239000004280 Sodium formate Substances 0.000 description 8
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 8
- 239000005937 Tebufenozide Substances 0.000 description 8
- 244000269722 Thea sinensis Species 0.000 description 8
- 235000009470 Theobroma cacao Nutrition 0.000 description 8
- 244000299461 Theobroma cacao Species 0.000 description 8
- 235000010749 Vicia faba Nutrition 0.000 description 8
- 240000006677 Vicia faba Species 0.000 description 8
- 235000002098 Vicia faba var. major Nutrition 0.000 description 8
- 239000011425 bamboo Substances 0.000 description 8
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 8
- 239000002775 capsule Substances 0.000 description 8
- CWFOCCVIPCEQCK-UHFFFAOYSA-N chlorfenapyr Chemical compound BrC1=C(C(F)(F)F)N(COCC)C(C=2C=CC(Cl)=CC=2)=C1C#N CWFOCCVIPCEQCK-UHFFFAOYSA-N 0.000 description 8
- 238000000576 coating method Methods 0.000 description 8
- 235000016213 coffee Nutrition 0.000 description 8
- 235000013353 coffee beverage Nutrition 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 239000002552 dosage form Substances 0.000 description 8
- 229920001971 elastomer Polymers 0.000 description 8
- YOWNVPAUWYHLQX-UHFFFAOYSA-N fluazuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC=C(Cl)C(OC=2C(=CC(=CN=2)C(F)(F)F)Cl)=C1 YOWNVPAUWYHLQX-UHFFFAOYSA-N 0.000 description 8
- 229950006719 fluazuron Drugs 0.000 description 8
- 235000004611 garlic Nutrition 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 239000000499 gel Substances 0.000 description 8
- 235000008434 ginseng Nutrition 0.000 description 8
- 239000004922 lacquer Substances 0.000 description 8
- 239000004530 micro-emulsion Substances 0.000 description 8
- 235000010460 mustard Nutrition 0.000 description 8
- 239000012053 oil suspension Substances 0.000 description 8
- 239000002674 ointment Substances 0.000 description 8
- 239000003973 paint Substances 0.000 description 8
- 239000008188 pellet Substances 0.000 description 8
- 239000004540 pour-on Substances 0.000 description 8
- DWFZBUWUXWZWKD-UHFFFAOYSA-N pyridaben Chemical compound C1=CC(C(C)(C)C)=CC=C1CSC1=C(Cl)C(=O)N(C(C)(C)C)N=C1 DWFZBUWUXWZWKD-UHFFFAOYSA-N 0.000 description 8
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 8
- 239000008247 solid mixture Substances 0.000 description 8
- 239000004550 soluble concentrate Substances 0.000 description 8
- 239000007921 spray Substances 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 238000013268 sustained release Methods 0.000 description 8
- 239000012730 sustained-release form Substances 0.000 description 8
- 235000013616 tea Nutrition 0.000 description 8
- QYPNKSZPJQQLRK-UHFFFAOYSA-N tebufenozide Chemical compound C1=CC(CC)=CC=C1C(=O)NN(C(C)(C)C)C(=O)C1=CC(C)=CC(C)=C1 QYPNKSZPJQQLRK-UHFFFAOYSA-N 0.000 description 8
- 235000013311 vegetables Nutrition 0.000 description 8
- 241000123650 Botrytis cinerea Species 0.000 description 7
- 210000000988 bone and bone Anatomy 0.000 description 7
- 230000001276 controlling effect Effects 0.000 description 7
- XGWIJUOSCAQSSV-XHDPSFHLSA-N (S,S)-hexythiazox Chemical compound S([C@H]([C@@H]1C)C=2C=CC(Cl)=CC=2)C(=O)N1C(=O)NC1CCCCC1 XGWIJUOSCAQSSV-XHDPSFHLSA-N 0.000 description 6
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 6
- 239000005874 Bifenthrin Substances 0.000 description 6
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 6
- 241001498622 Cixius wagneri Species 0.000 description 6
- 239000005760 Difenoconazole Substances 0.000 description 6
- 239000005782 Fluopicolide Substances 0.000 description 6
- 239000005790 Fosetyl Substances 0.000 description 6
- 241000255967 Helicoverpa zea Species 0.000 description 6
- 239000005661 Hexythiazox Substances 0.000 description 6
- 241000500437 Plutella xylostella Species 0.000 description 6
- 239000005842 Thiophanate-methyl Substances 0.000 description 6
- 241000255901 Tortricidae Species 0.000 description 6
- 241001464837 Viridiplantae Species 0.000 description 6
- OMFRMAHOUUJSGP-IRHGGOMRSA-N bifenthrin Chemical compound C1=CC=C(C=2C=CC=CC=2)C(C)=C1COC(=O)[C@@H]1[C@H](\C=C(/Cl)C(F)(F)F)C1(C)C OMFRMAHOUUJSGP-IRHGGOMRSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- BQYJATMQXGBDHF-UHFFFAOYSA-N difenoconazole Chemical compound O1C(C)COC1(C=1C(=CC(OC=2C=CC(Cl)=CC=2)=CC=1)Cl)CN1N=CN=C1 BQYJATMQXGBDHF-UHFFFAOYSA-N 0.000 description 6
- GBOYJIHYACSLGN-UHFFFAOYSA-N fluopicolide Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CNC(=O)C1=C(Cl)C=CC=C1Cl GBOYJIHYACSLGN-UHFFFAOYSA-N 0.000 description 6
- VUERQRKTYBIULR-UHFFFAOYSA-N fosetyl Chemical compound CCOP(O)=O VUERQRKTYBIULR-UHFFFAOYSA-N 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- QGHREAKMXXNCOA-UHFFFAOYSA-N thiophanate-methyl Chemical compound COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC QGHREAKMXXNCOA-UHFFFAOYSA-N 0.000 description 6
- 241001124076 Aphididae Species 0.000 description 5
- 241001414720 Cicadellidae Species 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- WHHIPMZEDGBUCC-UHFFFAOYSA-N probenazole Chemical compound C1=CC=C2C(OCC=C)=NS(=O)(=O)C2=C1 WHHIPMZEDGBUCC-UHFFFAOYSA-N 0.000 description 5
- ZXQYGBMAQZUVMI-RDDWSQKMSA-N (1S)-cis-(alphaR)-cyhalothrin Chemical compound CC1(C)[C@H](\C=C(/Cl)C(F)(F)F)[C@@H]1C(=O)O[C@@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-RDDWSQKMSA-N 0.000 description 4
- FHNKBSDJERHDHZ-UHFFFAOYSA-N (2,4-dimethylphenyl)methyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCC1=CC=C(C)C=C1C FHNKBSDJERHDHZ-UHFFFAOYSA-N 0.000 description 4
- ZMYFCFLJBGAQRS-IRXDYDNUSA-N (2R,3S)-epoxiconazole Chemical compound C1=CC(F)=CC=C1[C@@]1(CN2N=CN=C2)[C@H](C=2C(=CC=CC=2)Cl)O1 ZMYFCFLJBGAQRS-IRXDYDNUSA-N 0.000 description 4
- AMNAZJFEONUVTD-KEWDHRJRSA-N (2s,3s,4s,5r,6r)-6-(4-amino-2-oxopyrimidin-1-yl)-4,5-dihydroxy-3-[[(2s)-3-hydroxy-2-[[2-(methylamino)acetyl]amino]propanoyl]amino]oxane-2-carboxamide Chemical compound O1[C@H](C(N)=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC)[C@H](O)[C@@H](O)[C@@H]1N1C(=O)N=C(N)C=C1 AMNAZJFEONUVTD-KEWDHRJRSA-N 0.000 description 4
- QNBTYORWCCMPQP-JXAWBTAJSA-N (Z)-dimethomorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(Cl)=CC=1)=C/C(=O)N1CCOCC1 QNBTYORWCCMPQP-JXAWBTAJSA-N 0.000 description 4
- FNQJDLTXOVEEFB-UHFFFAOYSA-N 1,2,3-benzothiadiazole Chemical compound C1=CC=C2SN=NC2=C1 FNQJDLTXOVEEFB-UHFFFAOYSA-N 0.000 description 4
- HQZKNCJWLIWCSV-UHFFFAOYSA-N 3,4-dichloro-1,2-thiazole-5-carboxylic acid Chemical compound OC(=O)C=1SN=C(Cl)C=1Cl HQZKNCJWLIWCSV-UHFFFAOYSA-N 0.000 description 4
- BUQPTOSHKHYHHB-UHFFFAOYSA-N 3,5-dichloropyridine-4-carboxylic acid Chemical compound OC(=O)C1=C(Cl)C=NC=C1Cl BUQPTOSHKHYHHB-UHFFFAOYSA-N 0.000 description 4
- AJJFYSYXUHCPMZ-UHFFFAOYSA-N 3-(4-methyl-1,2,3-thiadiazolyl)-6-trichloromethyl[1,2,4]triazolo[3,4-b][1,3,4]thiadizole Chemical compound N1=NSC(C=2N3N=C(SC3NN=2)C(Cl)(Cl)Cl)=C1C AJJFYSYXUHCPMZ-UHFFFAOYSA-N 0.000 description 4
- OQEBBZSWEGYTPG-UHFFFAOYSA-N 3-aminobutanoic acid Chemical compound CC(N)CC(O)=O OQEBBZSWEGYTPG-UHFFFAOYSA-N 0.000 description 4
- NHHQOYLPBUYHQU-UHFFFAOYSA-N 4-methylthiadiazole-5-carboxylic acid Chemical compound CC=1N=NSC=1C(O)=O NHHQOYLPBUYHQU-UHFFFAOYSA-N 0.000 description 4
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 description 4
- 239000005964 Acibenzolar-S-methyl Substances 0.000 description 4
- 241001425390 Aphis fabae Species 0.000 description 4
- 241001347511 Carposina sasakii Species 0.000 description 4
- 241001481710 Cerambycidae Species 0.000 description 4
- 241000426497 Chilo suppressalis Species 0.000 description 4
- 239000005747 Chlorothalonil Substances 0.000 description 4
- 239000005654 Clofentezine Substances 0.000 description 4
- 241001465977 Coccoidea Species 0.000 description 4
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 description 4
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 4
- 241000254171 Curculionidae Species 0.000 description 4
- 239000005758 Cyprodinil Substances 0.000 description 4
- 239000005893 Diflubenzuron Substances 0.000 description 4
- 239000005761 Dimethomorph Substances 0.000 description 4
- 241000255925 Diptera Species 0.000 description 4
- 239000005767 Epoxiconazole Substances 0.000 description 4
- 239000005780 Fluazinam Substances 0.000 description 4
- 239000005789 Folpet Substances 0.000 description 4
- FEACDOXQOYCHKU-UHFFFAOYSA-N Gougerotin Natural products CNCC(=O)NC1=NC(=O)N(C=C1)C2OC(C(O)C(NC(=O)C(N)CO)C2O)C(=O)N FEACDOXQOYCHKU-UHFFFAOYSA-N 0.000 description 4
- 239000005797 Iprovalicarb Substances 0.000 description 4
- NWUWYYSKZYIQAE-ZBFHGGJFSA-N L-(R)-iprovalicarb Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C)C1=CC=C(C)C=C1 NWUWYYSKZYIQAE-ZBFHGGJFSA-N 0.000 description 4
- 239000005912 Lufenuron Substances 0.000 description 4
- 239000005808 Metalaxyl-M Substances 0.000 description 4
- 241000346285 Ostrinia furnacalis Species 0.000 description 4
- 240000001987 Pyrus communis Species 0.000 description 4
- 235000014443 Pyrus communis Nutrition 0.000 description 4
- 241000813090 Rhizoctonia solani Species 0.000 description 4
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 4
- 206010039509 Scab Diseases 0.000 description 4
- 241000221696 Sclerotinia sclerotiorum Species 0.000 description 4
- 239000005664 Spirodiclofen Substances 0.000 description 4
- 239000005658 Tebufenpyrad Substances 0.000 description 4
- 241001414989 Thysanoptera Species 0.000 description 4
- 239000005857 Trifloxystrobin Substances 0.000 description 4
- 229930195482 Validamycin Natural products 0.000 description 4
- YXWCBRDRVXHABN-JCMHNJIXSA-N [cyano-(4-fluoro-3-phenoxyphenyl)methyl] 3-[(z)-2-chloro-2-(4-chlorophenyl)ethenyl]-2,2-dimethylcyclopropane-1-carboxylate Chemical compound C=1C=C(F)C(OC=2C=CC=CC=2)=CC=1C(C#N)OC(=O)C1C(C)(C)C1\C=C(/Cl)C1=CC=C(Cl)C=C1 YXWCBRDRVXHABN-JCMHNJIXSA-N 0.000 description 4
- 229950008167 abamectin Drugs 0.000 description 4
- 239000003443 antiviral agent Substances 0.000 description 4
- 229930008659 antofine Natural products 0.000 description 4
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 description 4
- RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 description 4
- MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 4
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 4
- 229960005286 carbaryl Drugs 0.000 description 4
- CVXBEEMKQHEXEN-UHFFFAOYSA-N carbaryl Chemical compound C1=CC=C2C(OC(=O)NC)=CC=CC2=C1 CVXBEEMKQHEXEN-UHFFFAOYSA-N 0.000 description 4
- CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 description 4
- UXADOQPNKNTIHB-UHFFFAOYSA-N clofentezine Chemical compound ClC1=CC=CC=C1C1=NN=C(C=2C(=CC=CC=2)Cl)N=N1 UXADOQPNKNTIHB-UHFFFAOYSA-N 0.000 description 4
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 4
- 229960001591 cyfluthrin Drugs 0.000 description 4
- QQODLKZGRKWIFG-QSFXBCCZSA-N cyfluthrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-QSFXBCCZSA-N 0.000 description 4
- HAORKNGNJCEJBX-UHFFFAOYSA-N cyprodinil Chemical compound N=1C(C)=CC(C2CC2)=NC=1NC1=CC=CC=C1 HAORKNGNJCEJBX-UHFFFAOYSA-N 0.000 description 4
- OEBRKCOSUFCWJD-UHFFFAOYSA-N dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 description 4
- 229950001327 dichlorvos Drugs 0.000 description 4
- QQQYTWIFVNKMRW-UHFFFAOYSA-N diflubenzuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC=C(Cl)C=C1 QQQYTWIFVNKMRW-UHFFFAOYSA-N 0.000 description 4
- 229940019503 diflubenzuron Drugs 0.000 description 4
- YKBZOVFACRVRJN-UHFFFAOYSA-N dinotefuran Chemical compound [O-][N+](=O)\N=C(/NC)NCC1CCOC1 YKBZOVFACRVRJN-UHFFFAOYSA-N 0.000 description 4
- GCKZANITAMOIAR-XWVCPFKXSA-N dsstox_cid_14566 Chemical compound [O-]C(=O)C1=CC=CC=C1.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H]([NH2+]C)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 GCKZANITAMOIAR-XWVCPFKXSA-N 0.000 description 4
- DIRFUJHNVNOBMY-UHFFFAOYSA-N fenobucarb Chemical compound CCC(C)C1=CC=CC=C1OC(=O)NC DIRFUJHNVNOBMY-UHFFFAOYSA-N 0.000 description 4
- UZCGKGPEKUCDTF-UHFFFAOYSA-N fluazinam Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=C(Cl)C([N+]([O-])=O)=C1NC1=NC=C(C(F)(F)F)C=C1Cl UZCGKGPEKUCDTF-UHFFFAOYSA-N 0.000 description 4
- HKIOYBQGHSTUDB-UHFFFAOYSA-N folpet Chemical compound C1=CC=C2C(=O)N(SC(Cl)(Cl)Cl)C(=O)C2=C1 HKIOYBQGHSTUDB-UHFFFAOYSA-N 0.000 description 4
- WLPCAERCXQSYLQ-UHFFFAOYSA-N isotianil Chemical compound ClC1=NSC(C(=O)NC=2C(=CC=CC=2)C#N)=C1Cl WLPCAERCXQSYLQ-UHFFFAOYSA-N 0.000 description 4
- 239000005910 lambda-Cyhalothrin Substances 0.000 description 4
- 229960000521 lufenuron Drugs 0.000 description 4
- PWPJGUXAGUPAHP-UHFFFAOYSA-N lufenuron Chemical compound C1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=CC(Cl)=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F PWPJGUXAGUPAHP-UHFFFAOYSA-N 0.000 description 4
- ZQEIXNIJLIKNTD-GFCCVEGCSA-N metalaxyl-M Chemical compound COCC(=O)N([C@H](C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-GFCCVEGCSA-N 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 229960000490 permethrin Drugs 0.000 description 4
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 239000005962 plant activator Substances 0.000 description 4
- ZYHMJXZULPZUED-UHFFFAOYSA-N propargite Chemical compound C1=CC(C(C)(C)C)=CC=C1OC1C(OS(=O)OCC#C)CCCC1 ZYHMJXZULPZUED-UHFFFAOYSA-N 0.000 description 4
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 4
- 229960004889 salicylic acid Drugs 0.000 description 4
- DTDSAWVUFPGDMX-UHFFFAOYSA-N spirodiclofen Chemical compound CCC(C)(C)C(=O)OC1=C(C=2C(=CC(Cl)=CC=2)Cl)C(=O)OC11CCCCC1 DTDSAWVUFPGDMX-UHFFFAOYSA-N 0.000 description 4
- 239000010902 straw Substances 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 230000001502 supplementing effect Effects 0.000 description 4
- ZZYSLNWGKKDOML-UHFFFAOYSA-N tebufenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(=CC=2)C(C)(C)C)=C1Cl ZZYSLNWGKKDOML-UHFFFAOYSA-N 0.000 description 4
- WOSNCVAPUOFXEH-UHFFFAOYSA-N thifluzamide Chemical compound S1C(C)=NC(C(F)(F)F)=C1C(=O)NC1=C(Br)C=C(OC(F)(F)F)C=C1Br WOSNCVAPUOFXEH-UHFFFAOYSA-N 0.000 description 4
- VJQYLJSMBWXGDV-UHFFFAOYSA-N tiadinil Chemical compound N1=NSC(C(=O)NC=2C=C(Cl)C(C)=CC=2)=C1C VJQYLJSMBWXGDV-UHFFFAOYSA-N 0.000 description 4
- WPALTCMYPARVNV-UHFFFAOYSA-N tolfenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(OC=3C=CC(C)=CC=3)=CC=2)=C1Cl WPALTCMYPARVNV-UHFFFAOYSA-N 0.000 description 4
- ONCZDRURRATYFI-TVJDWZFNSA-N trifloxystrobin Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)C1=CC=CC(C(F)(F)F)=C1 ONCZDRURRATYFI-TVJDWZFNSA-N 0.000 description 4
- NCVWJDISIZHFQS-UHFFFAOYSA-N tylophorine B Natural products C12=CC(OC)=C(OC)C=C2C2=CC(OC)=CC=C2C2=C1CC1CCCN1C2 NCVWJDISIZHFQS-UHFFFAOYSA-N 0.000 description 4
- JARYYMUOCXVXNK-IMTORBKUSA-N validamycin Chemical compound N([C@H]1C[C@@H]([C@H]([C@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)CO)[C@H]1C=C(CO)[C@H](O)[C@H](O)[C@H]1O JARYYMUOCXVXNK-IMTORBKUSA-N 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 241000213004 Alternaria solani Species 0.000 description 3
- 241000223195 Fusarium graminearum Species 0.000 description 3
- 241000315044 Passalora arachidicola Species 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- 241001617088 Thanatephorus sasakii Species 0.000 description 3
- 231100000053 low toxicity Toxicity 0.000 description 3
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 3
- 229960000329 ribavirin Drugs 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- 238000001308 synthesis method Methods 0.000 description 3
- ZCVAOQKBXKSDMS-AQYZNVCMSA-N (+)-trans-allethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(CC=C)C(=O)C1 ZCVAOQKBXKSDMS-AQYZNVCMSA-N 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 2
- UIKROCXWUNQSPJ-VIFPVBQESA-N (-)-cotinine Chemical compound C1CC(=O)N(C)[C@@H]1C1=CC=CN=C1 UIKROCXWUNQSPJ-VIFPVBQESA-N 0.000 description 2
- KAATUXNTWXVJKI-NSHGMRRFSA-N (1R)-cis-(alphaS)-cypermethrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-NSHGMRRFSA-N 0.000 description 2
- NHOWDZOIZKMVAI-UHFFFAOYSA-N (2-chlorophenyl)(4-chlorophenyl)pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(Cl)C=C1 NHOWDZOIZKMVAI-UHFFFAOYSA-N 0.000 description 2
- RYAUSSKQMZRMAI-ALOPSCKCSA-N (2S,6R)-4-[3-(4-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1C[C@H](C)O[C@H](C)C1 RYAUSSKQMZRMAI-ALOPSCKCSA-N 0.000 description 2
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3ar,7as)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 description 2
- PPDBOQMNKNNODG-NTEUORMPSA-N (5E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentanol Chemical compound C1=NC=NN1CC1(O)C(C)(C)CC\C1=C/C1=CC=C(Cl)C=C1 PPDBOQMNKNNODG-NTEUORMPSA-N 0.000 description 2
- WCXDHFDTOYPNIE-RIYZIHGNSA-N (E)-acetamiprid Chemical compound N#C/N=C(\C)N(C)CC1=CC=C(Cl)N=C1 WCXDHFDTOYPNIE-RIYZIHGNSA-N 0.000 description 2
- PGOOBECODWQEAB-UHFFFAOYSA-N (E)-clothianidin Chemical compound [O-][N+](=O)\N=C(/NC)NCC1=CN=C(Cl)S1 PGOOBECODWQEAB-UHFFFAOYSA-N 0.000 description 2
- BKBSMMUEEAWFRX-NBVRZTHBSA-N (E)-flumorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(F)=CC=1)=C\C(=O)N1CCOCC1 BKBSMMUEEAWFRX-NBVRZTHBSA-N 0.000 description 2
- CFRPSFYHXJZSBI-DHZHZOJOSA-N (E)-nitenpyram Chemical compound [O-][N+](=O)/C=C(\NC)N(CC)CC1=CC=C(Cl)N=C1 CFRPSFYHXJZSBI-DHZHZOJOSA-N 0.000 description 2
- HOKKPVIRMVDYPB-UVTDQMKNSA-N (Z)-thiacloprid Chemical compound C1=NC(Cl)=CC=C1CN1C(=N/C#N)/SCC1 HOKKPVIRMVDYPB-UVTDQMKNSA-N 0.000 description 2
- ZAIDIVBQUMFXEC-UHFFFAOYSA-N 1,1-dichloroprop-1-ene Chemical group CC=C(Cl)Cl ZAIDIVBQUMFXEC-UHFFFAOYSA-N 0.000 description 2
- JWUCHKBSVLQQCO-UHFFFAOYSA-N 1-(2-fluorophenyl)-1-(4-fluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanol Chemical compound C=1C=C(F)C=CC=1C(C=1C(=CC=CC=1)F)(O)CN1C=NC=N1 JWUCHKBSVLQQCO-UHFFFAOYSA-N 0.000 description 2
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 2
- PXMNMQRDXWABCY-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol Chemical compound C1=NC=NN1CC(O)(C(C)(C)C)CCC1=CC=C(Cl)C=C1 PXMNMQRDXWABCY-UHFFFAOYSA-N 0.000 description 2
- VGPIBGGRCVEHQZ-UHFFFAOYSA-N 1-(biphenyl-4-yloxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC(C=C1)=CC=C1C1=CC=CC=C1 VGPIBGGRCVEHQZ-UHFFFAOYSA-N 0.000 description 2
- LQDARGUHUSPFNL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(COC(F)(F)C(F)F)CN1C=NC=N1 LQDARGUHUSPFNL-UHFFFAOYSA-N 0.000 description 2
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 description 2
- PZBPKYOVPCNPJY-UHFFFAOYSA-N 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=C)CN1C=NC=C1 PZBPKYOVPCNPJY-UHFFFAOYSA-N 0.000 description 2
- YIKWKLYQRFRGPM-UHFFFAOYSA-N 1-dodecylguanidine acetate Chemical compound CC(O)=O.CCCCCCCCCCCCN=C(N)N YIKWKLYQRFRGPM-UHFFFAOYSA-N 0.000 description 2
- PFFIDZXUXFLSSR-UHFFFAOYSA-N 1-methyl-N-[2-(4-methylpentan-2-yl)-3-thienyl]-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound S1C=CC(NC(=O)C=2C(=NN(C)C=2)C(F)(F)F)=C1C(C)CC(C)C PFFIDZXUXFLSSR-UHFFFAOYSA-N 0.000 description 2
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 2
- FMTFEIJHMMQUJI-NJAFHUGGSA-N 102130-98-3 Natural products CC=CCC1=C(C)[C@H](CC1=O)OC(=O)[C@@H]1[C@@H](C=C(C)C)C1(C)C FMTFEIJHMMQUJI-NJAFHUGGSA-N 0.000 description 2
- HUTNOYOBQPAKIA-UHFFFAOYSA-N 1h-pyrazin-2-one Chemical compound OC1=CN=CC=N1 HUTNOYOBQPAKIA-UHFFFAOYSA-N 0.000 description 2
- YTOPFCCWCSOHFV-UHFFFAOYSA-N 2,6-dimethyl-4-tridecylmorpholine Chemical compound CCCCCCCCCCCCCN1CC(C)OC(C)C1 YTOPFCCWCSOHFV-UHFFFAOYSA-N 0.000 description 2
- STMIIPIFODONDC-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(O)(CCCC)CN1C=NC=N1 STMIIPIFODONDC-UHFFFAOYSA-N 0.000 description 2
- HZJKXKUJVSEEFU-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile Chemical compound C=1C=C(Cl)C=CC=1C(CCCC)(C#N)CN1C=NC=N1 HZJKXKUJVSEEFU-UHFFFAOYSA-N 0.000 description 2
- UFNOUKDBUJZYDE-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C=CC(Cl)=CC=1)C(C)C1CC1 UFNOUKDBUJZYDE-UHFFFAOYSA-N 0.000 description 2
- YABFPHSQTSFWQB-UHFFFAOYSA-N 2-(4-fluorophenyl)-1-(1,2,4-triazol-1-yl)-3-(trimethylsilyl)propan-2-ol Chemical compound C=1C=C(F)C=CC=1C(O)(C[Si](C)(C)C)CN1C=NC=N1 YABFPHSQTSFWQB-UHFFFAOYSA-N 0.000 description 2
- MNHVNIJQQRJYDH-UHFFFAOYSA-N 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-1,2-dihydro-1,2,4-triazole-3-thione Chemical compound N1=CNC(=S)N1CC(C1(Cl)CC1)(O)CC1=CC=CC=C1Cl MNHVNIJQQRJYDH-UHFFFAOYSA-N 0.000 description 2
- YPSCQJTUAKNUNF-UHFFFAOYSA-N 2-chloro-n-[(4-chlorophenyl)carbamoyl]benzamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC(=O)C1=CC=CC=C1Cl YPSCQJTUAKNUNF-UHFFFAOYSA-N 0.000 description 2
- AWSZRJQNBMEZOI-UHFFFAOYSA-N 2-methoxyethyl 2-(4-tert-butylphenyl)-2-cyano-3-oxo-3-[2-(trifluoromethyl)phenyl]propanoate Chemical compound C=1C=C(C(C)(C)C)C=CC=1C(C#N)(C(=O)OCCOC)C(=O)C1=CC=CC=C1C(F)(F)F AWSZRJQNBMEZOI-UHFFFAOYSA-N 0.000 description 2
- IDPWXVBDDIYDKT-UHFFFAOYSA-N 2-phenoxyquinoline Chemical compound C=1C=C2C=CC=CC2=NC=1OC1=CC=CC=C1 IDPWXVBDDIYDKT-UHFFFAOYSA-N 0.000 description 2
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 description 2
- OVFHHJZHXHZIHT-UHFFFAOYSA-N 3-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl)quinazolin-4-one Chemical compound ClC1=CC(Cl)=CC=C1N1C(=O)C2=CC=CC=C2N=C1N1N=CN=C1 OVFHHJZHXHZIHT-UHFFFAOYSA-N 0.000 description 2
- FSCWZHGZWWDELK-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione Chemical compound O=C1C(C)(C=C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 FSCWZHGZWWDELK-UHFFFAOYSA-N 0.000 description 2
- NMWKWBPNKPGATC-UHFFFAOYSA-N 4,5,6,7-tetrachloro-2-benzofuran-1(3H)-one Chemical compound ClC1=C(Cl)C(Cl)=C2COC(=O)C2=C1Cl NMWKWBPNKPGATC-UHFFFAOYSA-N 0.000 description 2
- RQDJADAKIFFEKQ-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-phenyl-2-(1,2,4-triazol-1-ylmethyl)butanenitrile Chemical compound C1=CC(Cl)=CC=C1CCC(C=1C=CC=CC=1)(C#N)CN1N=CN=C1 RQDJADAKIFFEKQ-UHFFFAOYSA-N 0.000 description 2
- RALRVIPTUXSBPO-UHFFFAOYSA-N 4-[4-chloro-3-(trifluoromethyl)phenyl]piperidin-4-ol Chemical compound C=1C=C(Cl)C(C(F)(F)F)=CC=1C1(O)CCNCC1 RALRVIPTUXSBPO-UHFFFAOYSA-N 0.000 description 2
- BQMRHYBXRAYYQS-UHFFFAOYSA-N 4-dihydroxyphosphinothioyloxy-n,n-diethyl-6-methylpyrimidin-2-amine Chemical compound CCN(CC)C1=NC(C)=CC(OP(O)(O)=S)=N1 BQMRHYBXRAYYQS-UHFFFAOYSA-N 0.000 description 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 2
- NRTLIYOWLVMQBO-UHFFFAOYSA-N 5-chloro-1,3-dimethyl-N-(1,1,3-trimethyl-1,3-dihydro-2-benzofuran-4-yl)pyrazole-4-carboxamide Chemical compound C=12C(C)OC(C)(C)C2=CC=CC=1NC(=O)C=1C(C)=NN(C)C=1Cl NRTLIYOWLVMQBO-UHFFFAOYSA-N 0.000 description 2
- PCCSBWNGDMYFCW-UHFFFAOYSA-N 5-methyl-5-(4-phenoxyphenyl)-3-(phenylamino)-1,3-oxazolidine-2,4-dione Chemical compound O=C1C(C)(C=2C=CC(OC=3C=CC=CC=3)=CC=2)OC(=O)N1NC1=CC=CC=C1 PCCSBWNGDMYFCW-UHFFFAOYSA-N 0.000 description 2
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 description 2
- 239000005875 Acetamiprid Substances 0.000 description 2
- 241000555301 Agrius convolvuli Species 0.000 description 2
- 241000218473 Agrotis Species 0.000 description 2
- 241001600408 Aphis gossypii Species 0.000 description 2
- 235000015381 Aponogeton madagascariensis Nutrition 0.000 description 2
- 241001335589 Aponogeton madagascariensis Species 0.000 description 2
- 241000239290 Araneae Species 0.000 description 2
- 241001604418 Aromia bungii Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000005878 Azadirachtin Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000254127 Bemisia tabaci Species 0.000 description 2
- 239000005735 Benalaxyl-M Substances 0.000 description 2
- 239000005736 Benthiavalicarb Substances 0.000 description 2
- 239000005653 Bifenazate Substances 0.000 description 2
- QCFYJCYNJLBDRT-UHFFFAOYSA-N Bis(2-chloro-1-methylethyl)ether Chemical compound ClCC(C)OC(C)CCl QCFYJCYNJLBDRT-UHFFFAOYSA-N 0.000 description 2
- 239000005738 Bixafen Substances 0.000 description 2
- 108010006654 Bleomycin Proteins 0.000 description 2
- 240000008564 Boehmeria nivea Species 0.000 description 2
- 239000005740 Boscalid Substances 0.000 description 2
- RTONBWTZPZBIAC-UHFFFAOYSA-N Br[P]Br Chemical compound Br[P]Br RTONBWTZPZBIAC-UHFFFAOYSA-N 0.000 description 2
- 241000256593 Brachycaudus schwartzi Species 0.000 description 2
- 241000250967 Branchia Species 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- 241000233685 Bremia lactucae Species 0.000 description 2
- 239000005741 Bromuconazole Substances 0.000 description 2
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 2
- 241001414201 Bruchus pisorum Species 0.000 description 2
- 241001388466 Bruchus rufimanus Species 0.000 description 2
- 239000005742 Bupirimate Substances 0.000 description 2
- 239000005885 Buprofezin Substances 0.000 description 2
- 239000005745 Captan Substances 0.000 description 2
- 239000005746 Carboxin Substances 0.000 description 2
- 241000887125 Chaptalia nutans Species 0.000 description 2
- 239000005886 Chlorantraniliprole Substances 0.000 description 2
- 239000005944 Chlorpyrifos Substances 0.000 description 2
- 239000004099 Chlortetracycline Substances 0.000 description 2
- 239000005887 Chromafenozide Substances 0.000 description 2
- 241000931705 Cicada Species 0.000 description 2
- 241000132536 Cirsium Species 0.000 description 2
- 239000005888 Clothianidin Substances 0.000 description 2
- 241000008892 Cnaphalocrocis patnalis Species 0.000 description 2
- UIKROCXWUNQSPJ-UHFFFAOYSA-N Cotinine Natural products C1CC(=O)N(C)C1C1=CC=CN=C1 UIKROCXWUNQSPJ-UHFFFAOYSA-N 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 241000724252 Cucumber mosaic virus Species 0.000 description 2
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 2
- 239000005889 Cyantraniliprole Substances 0.000 description 2
- 239000005754 Cyazofamid Substances 0.000 description 2
- 239000005655 Cyflumetofen Substances 0.000 description 2
- 241000732800 Cymbidium Species 0.000 description 2
- 241000710147 Cymbidium ringspot virus Species 0.000 description 2
- 239000005757 Cyproconazole Substances 0.000 description 2
- 241000289763 Dasygaster padockina Species 0.000 description 2
- 239000005644 Dazomet Substances 0.000 description 2
- 241000084475 Delia antiqua Species 0.000 description 2
- AZJUFRDUYTYIHV-NKFKGCMQSA-N Dibenzoyl Thiamine Chemical compound C=1C=CC=CC=1C(=O)OCC\C(SC(=O)C=1C=CC=CC=1)=C(/C)N(C=O)CC1=CN=C(C)N=C1N AZJUFRDUYTYIHV-NKFKGCMQSA-N 0.000 description 2
- 241001060517 Dicranolaius bellulus Species 0.000 description 2
- 239000005759 Diethofencarb Substances 0.000 description 2
- 241000567556 Dinodon Species 0.000 description 2
- 239000005764 Dithianon Substances 0.000 description 2
- 239000005766 Dodine Substances 0.000 description 2
- 241000243686 Eisenia fetida Species 0.000 description 2
- 239000005894 Emamectin Substances 0.000 description 2
- 241001583841 Empoasca decipiens Species 0.000 description 2
- 241000738498 Epitrix pubescens Species 0.000 description 2
- 241000221785 Erysiphales Species 0.000 description 2
- 239000004258 Ethoxyquin Substances 0.000 description 2
- 239000005897 Etoxazole Substances 0.000 description 2
- 241000735527 Eupatorium Species 0.000 description 2
- 239000005772 Famoxadone Substances 0.000 description 2
- 239000005774 Fenamidone Substances 0.000 description 2
- 239000005958 Fenamiphos (aka phenamiphos) Substances 0.000 description 2
- 239000005775 Fenbuconazole Substances 0.000 description 2
- 239000005776 Fenhexamid Substances 0.000 description 2
- 239000005778 Fenpropimorph Substances 0.000 description 2
- 239000005657 Fenpyroximate Substances 0.000 description 2
- PNVJTZOFSHSLTO-UHFFFAOYSA-N Fenthion Chemical compound COP(=S)(OC)OC1=CC=C(SC)C(C)=C1 PNVJTZOFSHSLTO-UHFFFAOYSA-N 0.000 description 2
- 239000005901 Flubendiamide Substances 0.000 description 2
- 239000005783 Fluopyram Substances 0.000 description 2
- 239000005785 Fluquinconazole Substances 0.000 description 2
- 239000005786 Flutolanil Substances 0.000 description 2
- 239000005787 Flutriafol Substances 0.000 description 2
- 239000005788 Fluxapyroxad Substances 0.000 description 2
- 239000005959 Fosthiazate Substances 0.000 description 2
- 241001548941 Gastrodes abietum Species 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 241000578422 Graphosoma lineatum Species 0.000 description 2
- 241000241125 Gryllotalpa gryllotalpa Species 0.000 description 2
- 241001568505 Gryllotalpa orientalis Species 0.000 description 2
- 239000005794 Hymexazol Substances 0.000 description 2
- 239000005795 Imazalil Substances 0.000 description 2
- 239000005906 Imidacloprid Substances 0.000 description 2
- 239000005796 Ipconazole Substances 0.000 description 2
- 241000032989 Ipomoea lacunosa Species 0.000 description 2
- 239000005867 Iprodione Substances 0.000 description 2
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 2
- 241000981121 Leguminivora glycinivorella Species 0.000 description 2
- 241000254022 Locusta migratoria Species 0.000 description 2
- 241000721703 Lymantria dispar Species 0.000 description 2
- 239000005802 Mancozeb Substances 0.000 description 2
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 2
- 241001179564 Melanaphis sacchari Species 0.000 description 2
- 206010027146 Melanoderma Diseases 0.000 description 2
- 239000005805 Mepanipyrim Substances 0.000 description 2
- 239000005807 Metalaxyl Substances 0.000 description 2
- 239000002169 Metam Substances 0.000 description 2
- 239000005868 Metconazole Substances 0.000 description 2
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 2
- 239000005951 Methiocarb Substances 0.000 description 2
- 239000005917 Methoxyfenozide Substances 0.000 description 2
- 239000005810 Metrafenone Substances 0.000 description 2
- 239000005918 Milbemectin Substances 0.000 description 2
- 239000005811 Myclobutanil Substances 0.000 description 2
- 241000300102 Myiopardalis pardalina Species 0.000 description 2
- CFZLNRGUBAVQNO-UHFFFAOYSA-N N-(3,5-Dichlorophenyl)succinimide Chemical compound ClC1=CC(Cl)=CC(N2C(CCC2=O)=O)=C1 CFZLNRGUBAVQNO-UHFFFAOYSA-N 0.000 description 2
- NQRFDNJEBWAUBL-UHFFFAOYSA-N N-[cyano(2-thienyl)methyl]-4-ethyl-2-(ethylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NCC)=NC(CC)=C1C(=O)NC(C#N)C1=CC=CS1 NQRFDNJEBWAUBL-UHFFFAOYSA-N 0.000 description 2
- 241001556089 Nilaparvata lugens Species 0.000 description 2
- 241001012098 Omiodes indicata Species 0.000 description 2
- 239000005588 Oxadiazon Substances 0.000 description 2
- CHNUNORXWHYHNE-UHFFFAOYSA-N Oxadiazon Chemical compound C1=C(Cl)C(OC(C)C)=CC(N2C(OC(=N2)C(C)(C)C)=O)=C1Cl CHNUNORXWHYHNE-UHFFFAOYSA-N 0.000 description 2
- 241000488583 Panonychus ulmi Species 0.000 description 2
- 241000282376 Panthera tigris Species 0.000 description 2
- 241001622642 Parnara bada Species 0.000 description 2
- 241000721451 Pectinophora gossypiella Species 0.000 description 2
- 239000005813 Penconazole Substances 0.000 description 2
- 239000005814 Pencycuron Substances 0.000 description 2
- 239000005592 Penoxsulam Substances 0.000 description 2
- SYJGKVOENHZYMQ-UHFFFAOYSA-N Penoxsulam Chemical compound N1=C2C(OC)=CN=C(OC)N2N=C1NS(=O)(=O)C1=C(OCC(F)F)C=CC=C1C(F)(F)F SYJGKVOENHZYMQ-UHFFFAOYSA-N 0.000 description 2
- 239000005816 Penthiopyrad Substances 0.000 description 2
- 241000233679 Peronosporaceae Species 0.000 description 2
- 241000255129 Phlebotominae Species 0.000 description 2
- 241000233622 Phytophthora infestans Species 0.000 description 2
- 241000233647 Phytophthora nicotianae var. parasitica Species 0.000 description 2
- 239000005923 Pirimicarb Substances 0.000 description 2
- 229930182764 Polyoxin Natural products 0.000 description 2
- 239000005820 Prochloraz Substances 0.000 description 2
- RSVPPPHXAASNOL-UHFFFAOYSA-N Prodiamine Chemical compound CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C(N)=C1[N+]([O-])=O RSVPPPHXAASNOL-UHFFFAOYSA-N 0.000 description 2
- 239000005821 Propamocarb Substances 0.000 description 2
- 239000005822 Propiconazole Substances 0.000 description 2
- 239000005823 Propineb Substances 0.000 description 2
- 239000005825 Prothioconazole Substances 0.000 description 2
- 239000005606 Pyridate Substances 0.000 description 2
- JTZCTMAVMHRNTR-UHFFFAOYSA-N Pyridate Chemical compound CCCCCCCCSC(=O)OC1=CC(Cl)=NN=C1C1=CC=CC=C1 JTZCTMAVMHRNTR-UHFFFAOYSA-N 0.000 description 2
- 239000005828 Pyrimethanil Substances 0.000 description 2
- 241000125167 Rhopalosiphum padi Species 0.000 description 2
- 241000702632 Rice dwarf virus Species 0.000 description 2
- 241000563489 Sesamia inferens Species 0.000 description 2
- 241000254152 Sitophilus oryzae Species 0.000 description 2
- 241000753145 Sitotroga cerealella Species 0.000 description 2
- 241000256011 Sphingidae Species 0.000 description 2
- 239000005931 Spirotetramat Substances 0.000 description 2
- 239000005837 Spiroxamine Substances 0.000 description 2
- 241000256248 Spodoptera Species 0.000 description 2
- 241000256247 Spodoptera exigua Species 0.000 description 2
- 241000985245 Spodoptera litura Species 0.000 description 2
- 241001161749 Stenchaetothrips biformis Species 0.000 description 2
- 239000005935 Sulfuryl fluoride Substances 0.000 description 2
- 241000255632 Tabanus atratus Species 0.000 description 2
- 239000005839 Tebuconazole Substances 0.000 description 2
- 241000255588 Tephritidae Species 0.000 description 2
- 241000270708 Testudinidae Species 0.000 description 2
- 239000005840 Tetraconazole Substances 0.000 description 2
- 241001454294 Tetranychus Species 0.000 description 2
- 241001617320 Thalictrum flavum Species 0.000 description 2
- 239000005940 Thiacloprid Substances 0.000 description 2
- 239000005941 Thiamethoxam Substances 0.000 description 2
- 239000005843 Thiram Substances 0.000 description 2
- 241000339374 Thrips tabaci Species 0.000 description 2
- 239000005845 Tolclofos-methyl Substances 0.000 description 2
- 239000005846 Triadimenol Substances 0.000 description 2
- 241000018137 Trialeurodes vaporariorum Species 0.000 description 2
- 241000254113 Tribolium castaneum Species 0.000 description 2
- 239000005858 Triflumizole Substances 0.000 description 2
- 239000005859 Triticonazole Substances 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 208000000260 Warts Diseases 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 239000005870 Ziram Substances 0.000 description 2
- GBAWQJNHVWMTLU-RQJHMYQMSA-N [(1R,5S)-7-chloro-6-bicyclo[3.2.0]hepta-2,6-dienyl] dimethyl phosphate Chemical compound C1=CC[C@@H]2C(OP(=O)(OC)OC)=C(Cl)[C@@H]21 GBAWQJNHVWMTLU-RQJHMYQMSA-N 0.000 description 2
- SSNAAGFYBOZIEE-AMEPUADKSA-N [(e)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] diethyl phosphate;1-methoxy-4-[2,2,2-trichloro-1-(4-methoxyphenyl)ethyl]benzene Chemical compound CCOP(=O)(OCC)O\C(=C\Cl)C1=CC=C(Cl)C=C1Cl.C1=CC(OC)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(OC)C=C1 SSNAAGFYBOZIEE-AMEPUADKSA-N 0.000 description 2
- FSAVDKDHPDSCTO-WQLSENKSSA-N [(z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] diethyl phosphate Chemical compound CCOP(=O)(OCC)O\C(=C/Cl)C1=CC=C(Cl)C=C1Cl FSAVDKDHPDSCTO-WQLSENKSSA-N 0.000 description 2
- MWFQAAWRPDRKDG-KOLCDFICSA-N [2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl (1r,3s)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)[C@H]1C(C)(C)[C@@H]1C=C(Cl)Cl MWFQAAWRPDRKDG-KOLCDFICSA-N 0.000 description 2
- INISTDXBRIBGOC-CGAIIQECSA-N [cyano-(3-phenoxyphenyl)methyl] (2s)-2-[2-chloro-4-(trifluoromethyl)anilino]-3-methylbutanoate Chemical compound N([C@@H](C(C)C)C(=O)OC(C#N)C=1C=C(OC=2C=CC=CC=2)C=CC=1)C1=CC=C(C(F)(F)F)C=C1Cl INISTDXBRIBGOC-CGAIIQECSA-N 0.000 description 2
- 238000012271 agricultural production Methods 0.000 description 2
- 239000003905 agrochemical Substances 0.000 description 2
- 229940024113 allethrin Drugs 0.000 description 2
- ORFPWVRKFLOQHK-UHFFFAOYSA-N amicarbazone Chemical compound CC(C)C1=NN(C(=O)NC(C)(C)C)C(=O)N1N ORFPWVRKFLOQHK-UHFFFAOYSA-N 0.000 description 2
- VEHPJKVTJQSSKL-UHFFFAOYSA-N azadirachtin Natural products O1C2(C)C(C3(C=COC3O3)O)CC3C21C1(C)C(O)C(OCC2(OC(C)=O)C(CC3OC(=O)C(C)=CC)OC(C)=O)C2C32COC(C(=O)OC)(O)C12 VEHPJKVTJQSSKL-UHFFFAOYSA-N 0.000 description 2
- FTNJWQUOZFUQQJ-NDAWSKJSSA-N azadirachtin A Chemical compound C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C\C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-NDAWSKJSSA-N 0.000 description 2
- FTNJWQUOZFUQQJ-IRYYUVNJSA-N azadirachtin A Natural products C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C/C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-IRYYUVNJSA-N 0.000 description 2
- CJPQIRJHIZUAQP-MRXNPFEDSA-N benalaxyl-M Chemical compound CC=1C=CC=C(C)C=1N([C@H](C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-MRXNPFEDSA-N 0.000 description 2
- VVSLYIKSEBPRSN-PELKAZGASA-N benthiavalicarb Chemical compound C1=C(F)C=C2SC([C@@H](C)NC(=O)[C@@H](NC(O)=O)C(C)C)=NC2=C1 VVSLYIKSEBPRSN-PELKAZGASA-N 0.000 description 2
- 229950006791 bentiamine Drugs 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 229960002903 benzyl benzoate Drugs 0.000 description 2
- VHLKTXFWDRXILV-UHFFFAOYSA-N bifenazate Chemical compound C1=C(NNC(=O)OC(C)C)C(OC)=CC=C1C1=CC=CC=C1 VHLKTXFWDRXILV-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- LDLMOOXUCMHBMZ-UHFFFAOYSA-N bixafen Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=C(F)C=C1C1=CC=C(Cl)C(Cl)=C1 LDLMOOXUCMHBMZ-UHFFFAOYSA-N 0.000 description 2
- 229930189065 blasticidin Natural products 0.000 description 2
- 229960001561 bleomycin Drugs 0.000 description 2
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 2
- 229940118790 boscalid Drugs 0.000 description 2
- WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 description 2
- OJGDCBLYJGHCIH-UHFFFAOYSA-N bromhexine Chemical compound C1CCCCC1N(C)CC1=CC(Br)=CC(Br)=C1N OJGDCBLYJGHCIH-UHFFFAOYSA-N 0.000 description 2
- 229960003870 bromhexine Drugs 0.000 description 2
- FOANIXZHAMJWOI-UHFFFAOYSA-N bromopropylate Chemical compound C=1C=C(Br)C=CC=1C(O)(C(=O)OC(C)C)C1=CC=C(Br)C=C1 FOANIXZHAMJWOI-UHFFFAOYSA-N 0.000 description 2
- HJJVPARKXDDIQD-UHFFFAOYSA-N bromuconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCC(Br)C1 HJJVPARKXDDIQD-UHFFFAOYSA-N 0.000 description 2
- 229960003168 bronopol Drugs 0.000 description 2
- DSKJPMWIHSOYEA-UHFFFAOYSA-N bupirimate Chemical compound CCCCC1=C(C)N=C(NCC)N=C1OS(=O)(=O)N(C)C DSKJPMWIHSOYEA-UHFFFAOYSA-N 0.000 description 2
- PRLVTUNWOQKEAI-VKAVYKQESA-N buprofezin Chemical compound O=C1N(C(C)C)\C(=N\C(C)(C)C)SCN1C1=CC=CC=C1 PRLVTUNWOQKEAI-VKAVYKQESA-N 0.000 description 2
- 229940117949 captan Drugs 0.000 description 2
- DUEPRVBVGDRKAG-UHFFFAOYSA-N carbofuran Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2 DUEPRVBVGDRKAG-UHFFFAOYSA-N 0.000 description 2
- GYSSRZJIHXQEHQ-UHFFFAOYSA-N carboxin Chemical compound S1CCOC(C)=C1C(=O)NC1=CC=CC=C1 GYSSRZJIHXQEHQ-UHFFFAOYSA-N 0.000 description 2
- IRUJZVNXZWPBMU-UHFFFAOYSA-N cartap Chemical compound NC(=O)SCC(N(C)C)CSC(N)=O IRUJZVNXZWPBMU-UHFFFAOYSA-N 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- PSOVNZZNOMJUBI-UHFFFAOYSA-N chlorantraniliprole Chemical compound CNC(=O)C1=CC(Cl)=CC(C)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl PSOVNZZNOMJUBI-UHFFFAOYSA-N 0.000 description 2
- VUHJZBBCZGVNDZ-TTYLFXKOSA-N chlormadinone Chemical compound C1=C(Cl)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2 VUHJZBBCZGVNDZ-TTYLFXKOSA-N 0.000 description 2
- 229960003996 chlormadinone Drugs 0.000 description 2
- QGTYWWGEWOBMAK-UHFFFAOYSA-N chlormephos Chemical compound CCOP(=S)(OCC)SCCl QGTYWWGEWOBMAK-UHFFFAOYSA-N 0.000 description 2
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 2
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 description 2
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 2
- 229960004475 chlortetracycline Drugs 0.000 description 2
- 235000019365 chlortetracycline Nutrition 0.000 description 2
- HPNSNYBUADCFDR-UHFFFAOYSA-N chromafenozide Chemical compound CC1=CC(C)=CC(C(=O)N(NC(=O)C=2C(=C3CCCOC3=CC=2)C)C(C)(C)C)=C1 HPNSNYBUADCFDR-UHFFFAOYSA-N 0.000 description 2
- BERDEBHAJNAUOM-UHFFFAOYSA-N copper(I) oxide Inorganic materials [Cu]O[Cu] BERDEBHAJNAUOM-UHFFFAOYSA-N 0.000 description 2
- NWFNSTOSIVLCJA-UHFFFAOYSA-L copper;diacetate;hydrate Chemical compound O.[Cu+2].CC([O-])=O.CC([O-])=O NWFNSTOSIVLCJA-UHFFFAOYSA-L 0.000 description 2
- 229950006073 cotinine Drugs 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 229960003280 cupric chloride Drugs 0.000 description 2
- 229960004643 cupric oxide Drugs 0.000 description 2
- 229940112669 cuprous oxide Drugs 0.000 description 2
- KRFJLUBVMFXRPN-UHFFFAOYSA-N cuprous oxide Chemical compound [O-2].[Cu+].[Cu+] KRFJLUBVMFXRPN-UHFFFAOYSA-N 0.000 description 2
- DVBUIBGJRQBEDP-UHFFFAOYSA-N cyantraniliprole Chemical compound CNC(=O)C1=CC(C#N)=CC(C)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl DVBUIBGJRQBEDP-UHFFFAOYSA-N 0.000 description 2
- YXKMMRDKEKCERS-UHFFFAOYSA-N cyazofamid Chemical compound CN(C)S(=O)(=O)N1C(C#N)=NC(Cl)=C1C1=CC=C(C)C=C1 YXKMMRDKEKCERS-UHFFFAOYSA-N 0.000 description 2
- NNRSYETYEADPBW-UHFFFAOYSA-N cyhalodiamide Chemical compound CC1=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C1NC(=O)C1=CC=CC(Cl)=C1C(=O)NC(C)(C)C#N NNRSYETYEADPBW-UHFFFAOYSA-N 0.000 description 2
- ZXQYGBMAQZUVMI-UNOMPAQXSA-N cyhalothrin Chemical compound CC1(C)C(\C=C(/Cl)C(F)(F)F)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-UNOMPAQXSA-N 0.000 description 2
- QAYICIQNSGETAS-UHFFFAOYSA-N dazomet Chemical compound CN1CSC(=S)N(C)C1 QAYICIQNSGETAS-UHFFFAOYSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 description 2
- LNJNFVJKDJYTEU-UHFFFAOYSA-N diethofencarb Chemical compound CCOC1=CC=C(NC(=O)OC(C)C)C=C1OCC LNJNFVJKDJYTEU-UHFFFAOYSA-N 0.000 description 2
- CJHXCRMKMMBYJQ-UHFFFAOYSA-N dimethirimol Chemical compound CCCCC1=C(C)NC(N(C)C)=NC1=O CJHXCRMKMMBYJQ-UHFFFAOYSA-N 0.000 description 2
- XREKLQOUFWBSFH-UHFFFAOYSA-N dimethyl 2-acetylbutanedioate Chemical compound COC(=O)CC(C(C)=O)C(=O)OC XREKLQOUFWBSFH-UHFFFAOYSA-N 0.000 description 2
- FBOUIAKEJMZPQG-BLXFFLACSA-N diniconazole-M Chemical compound C1=NC=NN1/C([C@H](O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-BLXFFLACSA-N 0.000 description 2
- PYZSVQVRHDXQSL-UHFFFAOYSA-N dithianon Chemical compound S1C(C#N)=C(C#N)SC2=C1C(=O)C1=CC=CC=C1C2=O PYZSVQVRHDXQSL-UHFFFAOYSA-N 0.000 description 2
- QLFZZSKTJWDQOS-YDBLARSUSA-N doramectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C3CCCCC3)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C QLFZZSKTJWDQOS-YDBLARSUSA-N 0.000 description 2
- 229960003997 doramectin Drugs 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- AWZOLILCOUMRDG-UHFFFAOYSA-N edifenphos Chemical compound C=1C=CC=CC=1SP(=O)(OCC)SC1=CC=CC=C1 AWZOLILCOUMRDG-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229960002125 enilconazole Drugs 0.000 description 2
- VMNULHCTRPXWFJ-UJSVPXBISA-N enoxastrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)\C=C\C1=CC=C(Cl)C=C1 VMNULHCTRPXWFJ-UJSVPXBISA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- RIZMRRKBZQXFOY-UHFFFAOYSA-N ethion Chemical compound CCOP(=S)(OCC)SCSP(=S)(OCC)OCC RIZMRRKBZQXFOY-UHFFFAOYSA-N 0.000 description 2
- BBXXLROWFHWFQY-UHFFFAOYSA-N ethirimol Chemical compound CCCCC1=C(C)NC(NCC)=NC1=O BBXXLROWFHWFQY-UHFFFAOYSA-N 0.000 description 2
- DECIPOUIJURFOJ-UHFFFAOYSA-N ethoxyquin Chemical compound N1C(C)(C)C=C(C)C2=CC(OCC)=CC=C21 DECIPOUIJURFOJ-UHFFFAOYSA-N 0.000 description 2
- 229940093500 ethoxyquin Drugs 0.000 description 2
- 235000019285 ethoxyquin Nutrition 0.000 description 2
- IXSZQYVWNJNRAL-UHFFFAOYSA-N etoxazole Chemical compound CCOC1=CC(C(C)(C)C)=CC=C1C1N=C(C=2C(=CC=CC=2F)F)OC1 IXSZQYVWNJNRAL-UHFFFAOYSA-N 0.000 description 2
- LMVPQMGRYSRMIW-KRWDZBQOSA-N fenamidone Chemical compound O=C([C@@](C)(N=C1SC)C=2C=CC=CC=2)N1NC1=CC=CC=C1 LMVPQMGRYSRMIW-KRWDZBQOSA-N 0.000 description 2
- ZCJPOPBZHLUFHF-UHFFFAOYSA-N fenamiphos Chemical compound CCOP(=O)(NC(C)C)OC1=CC=C(SC)C(C)=C1 ZCJPOPBZHLUFHF-UHFFFAOYSA-N 0.000 description 2
- VDLGAVXLJYLFDH-UHFFFAOYSA-N fenhexamid Chemical compound C=1C=C(O)C(Cl)=C(Cl)C=1NC(=O)C1(C)CCCCC1 VDLGAVXLJYLFDH-UHFFFAOYSA-N 0.000 description 2
- ZNOLGFHPUIJIMJ-UHFFFAOYSA-N fenitrothion Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C(C)=C1 ZNOLGFHPUIJIMJ-UHFFFAOYSA-N 0.000 description 2
- XQUXKZZNEFRCAW-UHFFFAOYSA-N fenpropathrin Chemical compound CC1(C)C(C)(C)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 XQUXKZZNEFRCAW-UHFFFAOYSA-N 0.000 description 2
- YYJNOYZRYGDPNH-MFKUBSTISA-N fenpyroximate Chemical compound C=1C=C(C(=O)OC(C)(C)C)C=CC=1CO/N=C/C=1C(C)=NN(C)C=1OC1=CC=CC=C1 YYJNOYZRYGDPNH-MFKUBSTISA-N 0.000 description 2
- MXWAGQASUDSFBG-RVDMUPIBSA-N fluacrypyrim Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC(C(F)(F)F)=NC(OC(C)C)=N1 MXWAGQASUDSFBG-RVDMUPIBSA-N 0.000 description 2
- ZGNITFSDLCMLGI-UHFFFAOYSA-N flubendiamide Chemical compound CC1=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C1NC(=O)C1=CC=CC(I)=C1C(=O)NC(C)(C)CS(C)(=O)=O ZGNITFSDLCMLGI-UHFFFAOYSA-N 0.000 description 2
- RYLHNOVXKPXDIP-UHFFFAOYSA-N flufenoxuron Chemical compound C=1C=C(NC(=O)NC(=O)C=2C(=CC=CC=2F)F)C(F)=CC=1OC1=CC=C(C(F)(F)F)C=C1Cl RYLHNOVXKPXDIP-UHFFFAOYSA-N 0.000 description 2
- WFZSZAXUALBVNX-UHFFFAOYSA-N flufenpyr Chemical compound O=C1C(C)=C(C(F)(F)F)C=NN1C1=CC(OCC(O)=O)=C(Cl)C=C1F WFZSZAXUALBVNX-UHFFFAOYSA-N 0.000 description 2
- 229940043075 fluocinolone Drugs 0.000 description 2
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 2
- KVDJTXBXMWJJEF-UHFFFAOYSA-N fluopyram Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CCNC(=O)C1=CC=CC=C1C(F)(F)F KVDJTXBXMWJJEF-UHFFFAOYSA-N 0.000 description 2
- IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 description 2
- FQKUGOMFVDPBIZ-UHFFFAOYSA-N flusilazole Chemical compound C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 FQKUGOMFVDPBIZ-UHFFFAOYSA-N 0.000 description 2
- PTCGDEVVHUXTMP-UHFFFAOYSA-N flutolanil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C(F)(F)F)=C1 PTCGDEVVHUXTMP-UHFFFAOYSA-N 0.000 description 2
- SXSGXWCSHSVPGB-UHFFFAOYSA-N fluxapyroxad Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1=CC(F)=C(F)C(F)=C1 SXSGXWCSHSVPGB-UHFFFAOYSA-N 0.000 description 2
- DUFVKSUJRWYZQP-UHFFFAOYSA-N fosthiazate Chemical compound CCC(C)SP(=O)(OCC)N1CCSC1=O DUFVKSUJRWYZQP-UHFFFAOYSA-N 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 150000002391 heterocyclic compounds Chemical class 0.000 description 2
- KGVPNLBXJKTABS-UHFFFAOYSA-N hymexazol Chemical compound CC1=CC(O)=NO1 KGVPNLBXJKTABS-UHFFFAOYSA-N 0.000 description 2
- AGKSTYPVMZODRV-UHFFFAOYSA-N imibenconazole Chemical compound C1=CC(Cl)=CC=C1CSC(CN1N=CN=C1)=NC1=CC=C(Cl)C=C1Cl AGKSTYPVMZODRV-UHFFFAOYSA-N 0.000 description 2
- 229940056881 imidacloprid Drugs 0.000 description 2
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- QTYCMDBMOLSEAM-UHFFFAOYSA-N ipconazole Chemical compound C1=NC=NN1CC1(O)C(C(C)C)CCC1CC1=CC=C(Cl)C=C1 QTYCMDBMOLSEAM-UHFFFAOYSA-N 0.000 description 2
- FCOAHACKGGIURQ-UHFFFAOYSA-N iprobenfos Chemical compound CC(C)OP(=O)(OC(C)C)SCC1=CC=CC=C1 FCOAHACKGGIURQ-UHFFFAOYSA-N 0.000 description 2
- ONUFESLQCSAYKA-UHFFFAOYSA-N iprodione Chemical compound O=C1N(C(=O)NC(C)C)CC(=O)N1C1=CC(Cl)=CC(Cl)=C1 ONUFESLQCSAYKA-UHFFFAOYSA-N 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- YFVOXLJXJBQDEF-UHFFFAOYSA-N isocarbophos Chemical compound COP(N)(=S)OC1=CC=CC=C1C(=O)OC(C)C YFVOXLJXJBQDEF-UHFFFAOYSA-N 0.000 description 2
- QBSJMKIUCUGGNG-UHFFFAOYSA-N isoprocarb Chemical compound CNC(=O)OC1=CC=CC=C1C(C)C QBSJMKIUCUGGNG-UHFFFAOYSA-N 0.000 description 2
- UFHLMYOGRXOCSL-UHFFFAOYSA-N isoprothiolane Chemical compound CC(C)OC(=O)C(C(=O)OC(C)C)=C1SCCS1 UFHLMYOGRXOCSL-UHFFFAOYSA-N 0.000 description 2
- 229960002418 ivermectin Drugs 0.000 description 2
- PVTHJAPFENJVNC-MHRBZPPQSA-N kasugamycin Chemical compound N[C@H]1C[C@H](NC(=N)C(O)=O)[C@@H](C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O PVTHJAPFENJVNC-MHRBZPPQSA-N 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229930014456 matrine Natural products 0.000 description 2
- 229940103185 mefenamate Drugs 0.000 description 2
- HYYBABOKPJLUIN-UHFFFAOYSA-N mefenamic acid Chemical compound CC1=CC=CC(NC=2C(=CC=CC=2)C(O)=O)=C1C HYYBABOKPJLUIN-UHFFFAOYSA-N 0.000 description 2
- CIFWZNRJIBNXRE-UHFFFAOYSA-N mepanipyrim Chemical compound CC#CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 CIFWZNRJIBNXRE-UHFFFAOYSA-N 0.000 description 2
- HYVVJDQGXFXBRZ-UHFFFAOYSA-N metam Chemical compound CNC(S)=S HYVVJDQGXFXBRZ-UHFFFAOYSA-N 0.000 description 2
- XWPZUHJBOLQNMN-UHFFFAOYSA-N metconazole Chemical compound C1=NC=NN1CC1(O)C(C)(C)CCC1CC1=CC=C(Cl)C=C1 XWPZUHJBOLQNMN-UHFFFAOYSA-N 0.000 description 2
- YFBPRJGDJKVWAH-UHFFFAOYSA-N methiocarb Chemical compound CNC(=O)OC1=CC(C)=C(SC)C(C)=C1 YFBPRJGDJKVWAH-UHFFFAOYSA-N 0.000 description 2
- 229950003442 methoprene Drugs 0.000 description 2
- 229930002897 methoprene Natural products 0.000 description 2
- QCAWEPFNJXQPAN-UHFFFAOYSA-N methoxyfenozide Chemical compound COC1=CC=CC(C(=O)NN(C(=O)C=2C=C(C)C=C(C)C=2)C(C)(C)C)=C1C QCAWEPFNJXQPAN-UHFFFAOYSA-N 0.000 description 2
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate Chemical compound COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 description 2
- CIEXPHRYOLIQQD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-2-furoylalaninate Chemical compound CC=1C=CC=C(C)C=1N(C(C)C(=O)OC)C(=O)C1=CC=CO1 CIEXPHRYOLIQQD-UHFFFAOYSA-N 0.000 description 2
- 229960003085 meticillin Drugs 0.000 description 2
- VOEYXMAFNDNNED-UHFFFAOYSA-N metolcarb Chemical compound CNC(=O)OC1=CC=CC(C)=C1 VOEYXMAFNDNNED-UHFFFAOYSA-N 0.000 description 2
- AMSPWOYQQAWRRM-UHFFFAOYSA-N metrafenone Chemical compound COC1=CC=C(Br)C(C)=C1C(=O)C1=C(C)C=C(OC)C(OC)=C1OC AMSPWOYQQAWRRM-UHFFFAOYSA-N 0.000 description 2
- ZLBGSRMUSVULIE-GSMJGMFJSA-N milbemycin A3 Chemical compound O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 ZLBGSRMUSVULIE-GSMJGMFJSA-N 0.000 description 2
- 235000019713 millet Nutrition 0.000 description 2
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- RJMUSRYZPJIFPJ-UHFFFAOYSA-N niclosamide Chemical compound OC1=CC=C(Cl)C=C1C(=O)NC1=CC=C([N+]([O-])=O)C=C1Cl RJMUSRYZPJIFPJ-UHFFFAOYSA-N 0.000 description 2
- 229960001920 niclosamide Drugs 0.000 description 2
- 229960002715 nicotine Drugs 0.000 description 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 2
- 229940079888 nitenpyram Drugs 0.000 description 2
- OGYFATSSENRIKG-UHFFFAOYSA-N pencycuron Chemical compound C1=CC(Cl)=CC=C1CN(C(=O)NC=1C=CC=CC=1)C1CCCC1 OGYFATSSENRIKG-UHFFFAOYSA-N 0.000 description 2
- WBTYBAGIHOISOQ-UHFFFAOYSA-N pent-4-en-1-yl 2-[(2-furylmethyl)(imidazol-1-ylcarbonyl)amino]butanoate Chemical compound C1=CN=CN1C(=O)N(C(CC)C(=O)OCCCC=C)CC1=CC=CO1 WBTYBAGIHOISOQ-UHFFFAOYSA-N 0.000 description 2
- LKPLKUMXSAEKID-UHFFFAOYSA-N pentachloronitrobenzene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl LKPLKUMXSAEKID-UHFFFAOYSA-N 0.000 description 2
- ATROHALUCMTWTB-OWBHPGMISA-N phoxim Chemical compound CCOP(=S)(OCC)O\N=C(\C#N)C1=CC=CC=C1 ATROHALUCMTWTB-OWBHPGMISA-N 0.000 description 2
- 229950001664 phoxim Drugs 0.000 description 2
- YFGYUFNIOHWBOB-UHFFFAOYSA-N pirimicarb Chemical compound CN(C)C(=O)OC1=NC(N(C)C)=NC(C)=C1C YFGYUFNIOHWBOB-UHFFFAOYSA-N 0.000 description 2
- 244000000003 plant pathogen Species 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- YEBIHIICWDDQOL-YBHNRIQQSA-N polyoxin Polymers O[C@@H]1[C@H](O)[C@@H](C(C=O)N)O[C@H]1N1C(=O)NC(=O)C(C(O)=O)=C1 YEBIHIICWDDQOL-YBHNRIQQSA-N 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- TVLSRXXIMLFWEO-UHFFFAOYSA-N prochloraz Chemical compound C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl TVLSRXXIMLFWEO-UHFFFAOYSA-N 0.000 description 2
- QXJKBPAVAHBARF-BETUJISGSA-N procymidone Chemical compound O=C([C@]1(C)C[C@@]1(C1=O)C)N1C1=CC(Cl)=CC(Cl)=C1 QXJKBPAVAHBARF-BETUJISGSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- WZZLDXDUQPOXNW-UHFFFAOYSA-N propamocarb Chemical compound CCCOC(=O)NCCCN(C)C WZZLDXDUQPOXNW-UHFFFAOYSA-N 0.000 description 2
- STJLVHWMYQXCPB-UHFFFAOYSA-N propiconazole Chemical compound O1C(CCC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 STJLVHWMYQXCPB-UHFFFAOYSA-N 0.000 description 2
- KKMLIVYBGSAJPM-UHFFFAOYSA-L propineb Chemical compound [Zn+2].[S-]C(=S)NC(C)CNC([S-])=S KKMLIVYBGSAJPM-UHFFFAOYSA-L 0.000 description 2
- CXJSOEPQXUCJSA-UHFFFAOYSA-N pyridaphenthion Chemical compound N1=C(OP(=S)(OCC)OCC)C=CC(=O)N1C1=CC=CC=C1 CXJSOEPQXUCJSA-UHFFFAOYSA-N 0.000 description 2
- ZLIBICFPKPWGIZ-UHFFFAOYSA-N pyrimethanil Chemical compound CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 ZLIBICFPKPWGIZ-UHFFFAOYSA-N 0.000 description 2
- XRJLAOUDSILTFT-UHFFFAOYSA-N pyroquilon Chemical compound O=C1CCC2=CC=CC3=C2N1CC3 XRJLAOUDSILTFT-UHFFFAOYSA-N 0.000 description 2
- JYQUHIFYBATCCY-UHFFFAOYSA-N quinalphos Chemical compound C1=CC=CC2=NC(OP(=S)(OCC)OCC)=CN=C21 JYQUHIFYBATCCY-UHFFFAOYSA-N 0.000 description 2
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229940080817 rotenone Drugs 0.000 description 2
- JUVIOZPCNVVQFO-UHFFFAOYSA-N rotenone Natural products O1C2=C3CC(C(C)=C)OC3=CC=C2C(=O)C2C1COC1=C2C=C(OC)C(OC)=C1 JUVIOZPCNVVQFO-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- MXMXHPPIGKYTAR-UHFFFAOYSA-N silthiofam Chemical compound CC=1SC([Si](C)(C)C)=C(C(=O)NCC=C)C=1C MXMXHPPIGKYTAR-UHFFFAOYSA-N 0.000 description 2
- 201000010153 skin papilloma Diseases 0.000 description 2
- 241000894007 species Species 0.000 description 2
- CLSVJBIHYWPGQY-GGYDESQDSA-N spirotetramat Chemical compound CCOC(=O)OC1=C(C=2C(=CC=C(C)C=2)C)C(=O)N[C@@]11CC[C@H](OC)CC1 CLSVJBIHYWPGQY-GGYDESQDSA-N 0.000 description 2
- PUYXTUJWRLOUCW-UHFFFAOYSA-N spiroxamine Chemical compound O1C(CN(CC)CCC)COC11CCC(C(C)(C)C)CC1 PUYXTUJWRLOUCW-UHFFFAOYSA-N 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- OBTWBSRJZRCYQV-UHFFFAOYSA-N sulfuryl difluoride Chemical compound FS(F)(=O)=O OBTWBSRJZRCYQV-UHFFFAOYSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000004308 thiabendazole Substances 0.000 description 2
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 2
- 229960004546 thiabendazole Drugs 0.000 description 2
- 235000010296 thiabendazole Nutrition 0.000 description 2
- NWWZPOKUUAIXIW-FLIBITNWSA-N thiamethoxam Chemical compound [O-][N+](=O)\N=C/1N(C)COCN\1CC1=CN=C(Cl)S1 NWWZPOKUUAIXIW-FLIBITNWSA-N 0.000 description 2
- YFNCATAIYKQPOO-UHFFFAOYSA-N thiophanate Chemical compound CCOC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OCC YFNCATAIYKQPOO-UHFFFAOYSA-N 0.000 description 2
- QSOHVSNIQHGFJU-UHFFFAOYSA-L thiosultap disodium Chemical compound [Na+].[Na+].[O-]S(=O)(=O)SCC(N(C)C)CSS([O-])(=O)=O QSOHVSNIQHGFJU-UHFFFAOYSA-L 0.000 description 2
- MBNMHBAJUNHZRE-UHFFFAOYSA-M thiosultap monosodium Chemical compound [Na+].OS(=O)(=O)SCC(N(C)C)CSS([O-])(=O)=O MBNMHBAJUNHZRE-UHFFFAOYSA-M 0.000 description 2
- 229960002447 thiram Drugs 0.000 description 2
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 description 2
- OBZIQQJJIKNWNO-UHFFFAOYSA-N tolclofos-methyl Chemical compound COP(=S)(OC)OC1=C(Cl)C=C(C)C=C1Cl OBZIQQJJIKNWNO-UHFFFAOYSA-N 0.000 description 2
- BAZVSMNPJJMILC-UHFFFAOYSA-N triadimenol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC1=CC=C(Cl)C=C1 BAZVSMNPJJMILC-UHFFFAOYSA-N 0.000 description 2
- DQJCHOQLCLEDLL-UHFFFAOYSA-N tricyclazole Chemical compound CC1=CC=CC2=C1N1C=NN=C1S2 DQJCHOQLCLEDLL-UHFFFAOYSA-N 0.000 description 2
- HSMVPDGQOIQYSR-KGENOOAVSA-N triflumizole Chemical compound C1=CN=CN1C(/COCCC)=N/C1=CC=C(Cl)C=C1C(F)(F)F HSMVPDGQOIQYSR-KGENOOAVSA-N 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 238000009333 weeding Methods 0.000 description 2
- DUBNHZYBDBBJHD-UHFFFAOYSA-L ziram Chemical compound [Zn+2].CN(C)C([S-])=S.CN(C)C([S-])=S DUBNHZYBDBBJHD-UHFFFAOYSA-L 0.000 description 2
- BQTRMYJYYNQQGK-UHFFFAOYSA-N 1-(bromomethyl)-4-iodobenzene Chemical compound BrCC1=CC=C(I)C=C1 BQTRMYJYYNQQGK-UHFFFAOYSA-N 0.000 description 1
- BITDLWAQPKSXTF-UHFFFAOYSA-M 1-[(3-nitrophenyl)methoxymethyl]pyridin-1-ium;chloride Chemical compound [Cl-].[O-][N+](=O)C1=CC=CC(COC[N+]=2C=CC=CC=2)=C1 BITDLWAQPKSXTF-UHFFFAOYSA-M 0.000 description 1
- SQSYNRCXIZHKAI-UHFFFAOYSA-N 2,6-dichloroisonicotinic acid Chemical compound OC(=O)C1=CC(Cl)=NC(Cl)=C1 SQSYNRCXIZHKAI-UHFFFAOYSA-N 0.000 description 1
- AJVPPRMYXQSRIB-UHFFFAOYSA-N 2-chloro-n-(cyanomethyl)pyridine-4-carboxamide Chemical compound ClC1=CC(C(=O)NCC#N)=CC=N1 AJVPPRMYXQSRIB-UHFFFAOYSA-N 0.000 description 1
- 241001674044 Blattodea Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000221662 Sclerotinia Species 0.000 description 1
- 241000723873 Tobacco mosaic virus Species 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 244000000005 bacterial plant pathogen Species 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 244000000004 fungal plant pathogen Species 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 229960002581 moroxydine hydrochloride Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000010883 osseointegration Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940100050 virazole Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
Abstract
The invention provides 1,3, 4-oxadiazole psoralen derivatives, a preparation method and application thereof, and particularly relates to the 1,3, 4-oxadiazole psoralen derivatives, wherein the general chemical structure formula of the derivatives is shown as formula I:
Description
Technical Field
The technical scheme of the invention belongs to the field of pesticides, and particularly relates to 1,3, 4-oxadiazole psoralen compounds and a preparation method and application thereof.
Background
As part of bio-rational pesticides, plant-derived pesticides, the development and research thereof have been the focus of new pesticide research. The plant source pesticide can be degraded in nature, and generally does not pollute the environment and agricultural products. The possibility of accumulating toxicity in the environment and human body is low, the pesticide composition is relatively safe to human and livestock, has the characteristics of low toxicity and low residue, and can maintain high quality of agricultural products (Lidaofie et al, southern agriculture, 2018, 72 (13): 40-42, 45.). Psoralen is an important botanical drug intermediate, and has wide application value in the fields of food, medicine, pesticide and the like. The agricultural bactericide prepared by using psoralen as an active ingredient has excellent bactericidal activity, can be applied to preventing and treating diseases of various crops, is particularly suitable for preventing and treating agricultural fungal diseases, such as sclerotinia rot of colza, rice sheath blight, wheat scab and the like, and is an ideal bactericide in agriculture.
The heterocyclic compound contains nitrogen, oxygen, sulfur and other atoms, has high-efficiency, low-toxicity and broad-spectrum biological activity, and plays an important role in the design and synthesis of novel green pesticides. The literature reports that five-membered heterocyclic compounds have various activities such as insect killing, bacteriostasis, weeding, plant growth regulation and the like (Chendanping and the like, modern pesticides, 2014, 14 (2): 5-10.); wherein, the 1,3, 4-oxadiazole is taken as a common nitrogen-containing five-membered heterocycle, has good biological activity and pharmacological activity, such as anti-tumor, anti-HIV, anti-convulsion, antivirus, insecticidal, weeding, sterilization and the like, and is widely applied to the fields of pesticide, medicine and the like (Yanzihui, Kunming academy of academic, 2017, 39 (6): 85-88.). For example, the herbicide oxadiazon can effectively prevent and kill various annual monocotyledon and dicotyledon weeds, and the pesticide oxadiazon has the contact poisoning or stomach poisoning effect on insects and can be used for preventing and controlling pests such as cockroaches, aphids, leafhoppers and the like. In addition, the organic electroluminescent material has excellent electron injection and transport functions and is widely applied to organic electroluminescent materials. And the parent nucleus structure has hydrogen bond acceptor characteristics and can effectively improve the lipophilicity and the pharmacokinetic characteristics of the drug, so that the 1,3, 4-oxadiazole structure is still often selected as an effective active group in the creation of new pesticides.
In order to search and discover pesticide lead and candidate compounds which are more efficient, broad-spectrum, low-toxicity, low-ecological risk and free of cross resistance, the invention introduces a 1,3, 4-oxadiazole structure into the lead structure of psoralen, designs and synthesizes 1,3, 4-oxadiazole psoralen derivatives, and screens and evaluates the biological activity of the system.
Disclosure of Invention
The technical problem to be solved by the invention is as follows: provides a synthesis method of a novel 1,3, 4-oxadiazole psoralen derivative, provides a method for regulating and controlling the biological activity of agricultural, horticultural and sanitary and forestry plant pests and plant pathogens by using the compound and a determination method thereof, and provides application of the compound in the agricultural field, the horticultural field, the forestry field and the sanitary field.
The technical scheme adopted by the invention for solving the technical problem is as follows: the chemical structural general formula of the 1,3, 4-oxadiazole psoralen compound with insecticidal, acaricidal, bactericidal, anti-plant virus and induced plant disease-resistant activities in the agricultural field, the horticultural field and the forestry field is shown as I:
wherein R is1Selected from: hydrogen, 4-fluoro; r2Selected from: 4-methylbenzyl, 4-fluorobenzyl, 3-methylbenzyl, 4-nitrobenzyl, o-methylbenzyl, 4-chlorobenzyl, propargyl, 4-iodobenzyl, n-propyl, 2-naphthylmethyl, allyl, 2, 4-dichlorobenzyl, 4-tert-butylbenzyl, cyclopropylmethyl, 4-chlorobenzoylmethyl, 2-cyano-5-picolyl, 3-bromobenzyl, (E) -2- (2-methoxy-1- (methoxyimino) -2-oxyethyl) benzyl, (E) -2- (1, 3-dimethoxy-3-oxoprop-1-en-2-yl) benzyl, 3-methylbenzylBut-2-enyl, benzoylmethyl, 4-trifluoromethoxybenzyl, 2- (4-chlorophenyl) ethyl.
The synthetic route of the 1,3, 4-oxadiazole psoralen derivative I and the intermediate thereof is as follows:
synthetic route to Compounds I
The synthesis method of the 1,3, 4-oxadiazole psoralen derivative I comprises the following steps:
A. preparation of compound 3:
putting the compound 1 into a reaction bottle, adding the compound 2, then slowly dropwise adding 98% concentrated sulfuric acid while stirring, and stirring at room temperature; after the reaction is finished, adding a proper amount of methanol, then pouring the methanol into ice water to generate a large amount of white solid, and performing suction filtration and drying to obtain a compound 3;
B. preparation of compound 5:
putting the compound 3 into a reaction bottle, adding a proper amount of anhydrous acetonitrile, then sequentially adding potassium carbonate, potassium iodide and the compound 4 while stirring, and heating and refluxing; after the reaction is finished, removing most of acetonitrile under reduced pressure, adding water and ethyl acetate for extraction, washing an organic phase by using a saturated sodium chloride solution, drying anhydrous sodium sulfate, carrying out suction filtration under reduced pressure, concentrating a filtrate to remove a solvent, and carrying out column chromatography purification to obtain a compound 5;
C. preparation of compound 6:
adding a compound 5 into a reaction bottle, adding a proper amount of isopropanol, slowly dropwise adding 1 mol/L sodium hydroxide solution while stirring, and heating and refluxing; after the reaction is finished, removing most of isopropanol under reduced pressure, adjusting the pH of the system to be 1-2 by using 1 mol/L hydrochloric acid solution, and performing suction filtration and drying on the generated solid to obtain a compound 6;
D. preparation of compound 7:
taking the compound 6, adding a proper amount of anhydrous methanol into a reaction bottle, then slowly dropwise adding 98% concentrated sulfuric acid while stirring, and heating and refluxing; after the reaction is finished, removing most of methanol under reduced pressure, adding water and ethyl acetate into the residue for extraction, washing an organic phase by using a saturated sodium chloride solution, drying the organic phase by using anhydrous sodium sulfate, carrying out suction filtration under reduced pressure, concentrating the filtrate to remove the solvent, and carrying out column chromatography purification to obtain a compound 7;
E. preparation of compound 8:
taking the compound 7, adding a proper amount of methanol into a reaction bottle, slowly dropwise adding 80% hydrazine hydrate while stirring, and heating and refluxing; after the reaction is finished, removing most of methanol under reduced pressure, adding water and ethyl acetate into the residue for extraction, washing an organic phase by using a saturated sodium chloride solution, drying by using anhydrous sodium sulfate, carrying out suction filtration under reduced pressure, concentrating the filtrate to remove the solvent, and carrying out column chromatography purification to obtain a compound 8;
F. preparation of compound 9:
putting the compound 8 into a reaction bottle, adding a proper amount of absolute ethyl alcohol, adding potassium hydroxide under stirring, then slowly dropwise adding carbon disulfide, and heating and refluxing; after the reaction is finished, removing most of ethanol under reduced pressure, adding 1 mol/L hydrochloric acid solution into the residue to adjust the pH of the system to be 1-2, extracting with ethyl acetate, washing an organic phase with saturated sodium chloride solution, drying with anhydrous sodium sulfate, carrying out suction filtration under reduced pressure, concentrating the filtrate to remove the solvent, and purifying by column chromatography to obtain a compound 9;
G. preparation of Compound I-a:
taking the compound 9, adding a proper amount of N, N-dimethylformamide into a reaction bottle, sequentially adding potassium hydroxide, chlorohydrocarbon or bromohydrocarbon, and stirring at room temperature; after the reaction is finished, adding a proper amount of water and ethyl acetate for extraction, washing an organic phase by using a saturated sodium chloride solution, drying by using anhydrous sodium sulfate, carrying out vacuum filtration, concentrating the filtrate to remove the solvent, and carrying out column chromatography purification to obtain a compound I-a;
H. preparation of Compound I-b:
under the condition of low-temperature ice bath, taking the compound I-a, adding a proper amount of dichloromethane into a reaction bottle, then slowly dropwise adding a dichloromethane solution dissolved with m-chloroperoxybenzoic acid, and moving the system to room temperature for stirring; after the reaction is finished, removing most dichloromethane under reduced pressure, adding a proper amount of ethyl acetate into the residue, washing the residue with 0.25 mol/L disodium hydrogen phosphate solution and saturated sodium chloride solution in sequence, drying the solution with anhydrous sodium sulfate, carrying out suction filtration under reduced pressure, concentrating the filtrate to remove the solvent, and carrying out column chromatography purification to obtain a compound I-b;
I. preparation of Compounds I-c:
under the condition of low-temperature ice bath, taking the compound I-a, adding a proper amount of acetic acid into a reaction bottle, slowly dropwise adding a hydrogen peroxide solution dissolved with ammonium molybdate while stirring, and then transferring the system to room temperature for stirring; after the reaction is finished, adding water and ethyl acetate for extraction, washing the organic phase with a saturated sodium bisulfate solution and a saturated sodium chloride solution successively, drying with anhydrous sodium sulfate, carrying out suction filtration under reduced pressure, concentrating the filtrate to remove the solvent, and carrying out column chromatography purification to obtain a compound I-c;
as a preferred embodiment, the synthesis method of the 1,3, 4-oxadiazole psoralen derivative provided by the invention comprises the following steps:
A. preparation of compound 3:
a100 ml round-bottom flask was charged with 18.2 mmol of resorcinol and 18.2 mmol of dimethyl acetylsuccinate, followed by slowly dropping 2.73 ml of 98% concentrated sulfuric acid under stirring, and after the dropping was completed, the reaction system was stirred at room temperature overnight. Monitoring by TLC, adding 30 ml of anhydrous methanol after the reaction is finished, pouring the anhydrous methanol into ice water to generate a large amount of white solid, performing suction filtration on the obtained solid, washing the crude product with diethyl ether, and recrystallizing with ethanol-water to obtain a compound 3; the amount of compound 3 produced and the volume of the reaction vessel are scaled up or down accordingly.
B. Preparation of compound 5:
in a 100 ml round-bottom flask were charged 4.03 mmol of compound 3 and 30 ml of anhydrous acetonitrile, and 4.836 mmol of compound 4, 16.12 mmol of anhydrous potassium carbonate and 0.403 mmol of potassium iodide were sequentially added under stirring at room temperature, followed by heating and refluxing the reaction system for 5 hours. Monitoring by TLC, standing and cooling to room temperature after the reaction is finished, removing most of solvent under reduced pressure, adding 30 ml of water into the residue, extracting for three times (15 ml. times.3) by ethyl acetate, washing the organic phase for three times (15 ml. times.3) by saturated sodium chloride solution, and drying the combined organic layers by anhydrous sodium sulfate; vacuum filtering, concentrating the filtrate to remove solvent, and purifying with petroleum ether/ethyl acetate (3: 1, volume/volume) eluent column chromatography to obtain compound 5; the amount of compound 5 produced and the volume of the reaction vessel are scaled up or down accordingly.
C. Preparation of compound 6:
1 g of compound 5 and 30 ml of isopropanol are added into a 100 ml round-bottom flask, 30 ml of 1 mol/l sodium hydroxide solution is slowly added dropwise under stirring at room temperature, and the reaction system is heated and refluxed for 4 hours after the dropwise addition. Monitoring by TLC, standing the system after the reaction is finished, cooling to room temperature, removing most isopropanol under reduced pressure, adding 1 mol/L hydrochloric acid solution into the residue to adjust the pH of the system to 1, precipitating a large amount of solid, performing suction filtration, and drying to obtain a compound 6; the amount of compound 6 produced and the volume of the reaction vessel are scaled up or down accordingly.
D. Preparation of compound 7:
1 g of compound 6 and 30 ml of anhydrous methanol are added into a 100 ml round-bottom flask, 1.5 ml of 98% concentrated sulfuric acid is slowly dropped into the flask under stirring at room temperature, and the reaction system is heated and refluxed for 5 hours after the dropping is finished. Monitoring by TLC, after the reaction is finished, standing the system to cool to room temperature, removing most methanol under reduced pressure, adding 30 ml of water into the residue, extracting three times with ethyl acetate (15 ml. times.3), washing the organic phase with saturated sodium chloride solution for three times (15 ml. times.3), and drying the combined organic layers with anhydrous sodium sulfate; vacuum filtering, concentrating the filtrate to remove solvent, and purifying with petroleum ether/ethyl acetate (3: 1, volume/volume) eluent column chromatography to obtain compound 7; the amount of compound 7 produced and the volume of the reaction vessel are scaled up or down accordingly.
E. Preparation of compound 8:
a100 ml round-bottom flask was charged with 1 mmol of Compound 7 and 30 ml of methanol, and 4 mmol of 80% hydrazine hydrate was slowly added dropwise with stirring at room temperature, and the reaction system was heated under reflux for 8 hours after completion of the addition. Monitoring by TLC, after the reaction is finished, standing the system to cool to room temperature, removing most methanol under reduced pressure, adding 30 ml of water into the residue, extracting three times with ethyl acetate (15 ml. times.3), washing the organic phase with saturated sodium chloride solution for three times (15 ml. times.3), and drying the combined organic layers with anhydrous sodium sulfate; vacuum filtering, concentrating the filtrate to remove solvent, and purifying with dichloromethane/methanol (15: 1, volume/volume) eluent column chromatography to obtain compound 8; the amount of compound 8 produced and the volume of the reaction vessel are scaled up or down accordingly.
F. Preparation of compound 9:
a100 ml round-bottom flask was charged with 1 mmol of Compound 8 and 20 ml of anhydrous ethanol, 1.2 mmol of potassium hydroxide was added at room temperature with stirring, 3 mmol of carbon disulfide was slowly added after 5 minutes, and the reaction was heated to reflux for 6 hours. Monitoring by TLC, after the reaction is finished, standing the system, cooling to room temperature, removing most ethanol under reduced pressure, adding 15 ml of water into the residue, adjusting the pH of the system to 1-2 by using 1 mol/l hydrochloric acid solution, extracting three times (15 ml × 3) by using ethyl acetate, washing three times (15 ml × 3) by using saturated sodium chloride solution for an organic phase, and drying combined organic layers by using anhydrous sodium sulfate; vacuum filtering, concentrating the filtrate to remove solvent, and purifying with dichloromethane/methanol (17: 1, volume/volume) eluent column chromatography to obtain compound 9; the amount of compound 9 produced and the volume of the reaction vessel are scaled up or down accordingly.
G. Preparation of Compound I-a:
a100-ml round-bottom flask was charged with 1 mmol of compound 9 and 20 ml of N, N-dimethylformamide, and 2.3 mmol of potassium hydroxide and 1.2 mmol of bromohydrocarbon or chlorohydrocarbon were sequentially added thereto under stirring at room temperature, followed by stirring of the reaction system at room temperature for 8 hours. TLC, 15 ml of water was added after the reaction was complete, extracted three times with ethyl acetate (15 ml × 3), the organic phase was washed three times with saturated sodium chloride solution (15 ml × 3), and the combined organic layers were dried over anhydrous sodium sulfate; vacuum filtering, concentrating the filtrate to remove solvent, and purifying with dichloromethane/methanol (30: 1, volume/volume) eluent column chromatography to obtain compound I-a; the amount of compound I-a prepared and the volume of the reaction vessel are scaled up or down accordingly.
H. Preparation of Compound I-b:
1 mmol of the compound I-a and 20 ml of dichloromethane were added to a 100 ml round-bottomed flask under ice-bath at low temperature, 1.6 mmol of m-chloroperoxybenzoic acid was slowly added with stirring, and then the reaction system was moved to room temperature for 6 hours. TLC, after completion of the reaction most of the dichloromethane was removed under reduced pressure, extracted three times with ethyl acetate (15 ml × 3), the organic phase was washed three times with 0.25 mol/l disodium hydrogen phosphate solution (15 ml × 3) and saturated sodium chloride solution (15 ml × 3) in sequence, and the combined organic layers were dried over anhydrous sodium sulfate; vacuum filtering, concentrating the filtrate to remove solvent, and purifying with dichloromethane/methanol (40: 1, volume/volume) eluent column chromatography to obtain compound I-b; the amount of compound I-b prepared and the volume of the reaction vessel are scaled up or down accordingly.
I. Preparation of Compounds I-c:
under the condition of low-temperature ice bath, 1 mmol of the compound I-a and 20 ml of anhydrous acetic acid are added into a 100 ml round-bottom flask, a 30% hydrogen peroxide solution containing 0.05 mmol of ammonium molybdate is slowly added dropwise with stirring to 6 mmol, and then the reaction system is moved to room temperature for reaction for 8 hours. TLC, 15 ml of water was added after the reaction was complete, extraction was performed three times with ethyl acetate (15 ml × 3), the organic phase was washed three times with saturated sodium hydrogen sulfate solution (15 ml × 3) and saturated sodium chloride solution (15 ml × 3) in sequence, and the combined organic layers were dried over anhydrous sodium sulfate; vacuum filtering, concentrating the filtrate to remove solvent, and purifying with dichloromethane/methanol (20: 1, volume/volume) eluent column chromatography to obtain compound I-c; the amount of compound I-c prepared and the volume of the reaction vessel are scaled up or down accordingly.
Wherein R is1Selected from: hydrogen, 4-fluoro; r2Selected from: 4-methylbenzyl, 4-fluorobenzyl, 3-methylbenzyl, 4-nitrobenzyl, o-methylbenzyl, 4-chlorobenzyl, propargyl, 4-iodobenzyl, n-propyl, 2-naphthylmethyl, allyl, 2, 4-dichlorobenzyl, 4-tert-butylbenzyl, cyclopropylmethyl, 4-chlorobenzoylmethyl, 2-cyano-5-picolyl, 3-bromobenzyl, (E) -2- (2-methoxy-1- (methoxyimino) -2-oxyethyl) benzyl, (E) -2- (1, 3-dimethoxy-3-oxoprop-1-en-2-yl) benzyl, 3-methylbut-2-enyl, m-ethylbenzyl, n-propylbenzyl, n-2-propylbenzyl, p-ethylbenzyl, p-2-ethylbut-2-enyl, p-methyl-benzyl, p-2-ethylbenzyl, p-butyl-2-ethyl, p-benzyl, p-butyl-2-benzyl, p-methyl-2-benzyl, p-methyl, p-2-o-benzyl, p-methyl-benzyl, p-2-p, Benzoylmethyl, 4-trifluoromethoxybenzyl, 2- (4-chlorophenyl) ethyl.
The invention provides application of the 1,3, 4-oxadiazole psoralen derivative I in preparation of fungicides.
The invention provides application of the 1,3, 4-oxadiazole psoralen derivative I in preparation of an anti-tobacco mosaic virus agent.
The invention provides application of the 1,3, 4-oxadiazol psoralen derivative I in preparing a plant activator for inducing tobacco to resist tobacco mosaic virus.
The invention provides application of the 1,3, 4-oxadiazole psoralen derivative I in preventing and treating agricultural and forestry and horticultural plant insect pests.
The 1,3, 4-oxadiazole psoralen derivative I is applied together with agricultural chemicals; the agrochemical is selected from: one or more of insecticide, bactericide, plant virus resisting agent and acaricide.
The 1,3, 4-oxadiazole psoralen derivative I and any one or two of the insecticides are combined to form an insecticidal composition for preventing and treating insect pests of agricultural and forestry and horticultural plants;
the insecticide is selected from: methoprene, diazinon, acetamiprid, emamectin benzoate, milbemectin, abamectin, pleocidin, metaflumethrin, meperfluthrin, cyfluthrin, beta-cypermethrin, lambda-cyhalothrin, permethrin, allethrin, bifenthrin, permethrin, flumethrin, cyfluthrin, imidacloprid, nitenpyram, imidaclothianidin, thiacloprid, thiamethoxam, clothianidin, dinotefuran, cotinine, dinotefuran, diflubenzuron, chlorbenzuron, tefluazuron, flufenoxuron, lufenuron, chlorflufenoxuron, fluazuron, diflubenzuron, fluazuron, tezine, fluazuron, tezine, teflufenozide, tebufenozide, tezine, flufenozide, tebufenozide, tezine, tebufenozide, tezine, tebufenozide, tezine, tebufalin, tezine, tebenflumetsulbenflumetsulbens, tezine, tebenil, tezine, tebenil, tebenflumetsulbens, tebenil, tebens, tezine, tebens, and tebens, and the like, Methoxyfenozide, chromafenozide, dichlorvos, quinalphos, pyridaphenthion, cicada powder, carbaryl, pirimicarb, metolcarb, isoprocarb, cartap, fenobucarb, tetrafenozide, fenitrothion, hexythiazox, carbaryl, fenisobromolate, hexythiazox, pyridate, clofentezine, spirodiclofen, spirotetramat, azocyclobutazine, buprofezin, monosultap, dimehypo, chlorantraniliprole, tetrachlorantranilide, flubendiamide, cyantraniliprole, butenenitrile, tolfenpyrad, chlorfenapyr, pyrazofos, pyrazinone, etoxazole, tebufenpyrad, pyridaben, emamectin, and pentapyraflufen;
the mass percentage of the 1,3, 4-oxadiazole psoralen derivative I in the insecticidal composition is 1% -90%; preferably, the mass percentage of the 1,3, 4-oxadiazole psoralen derivative I to the pesticide is 1 to 99 to 1;
the insecticide composition is processed into a dosage form selected from the group consisting of: seed treatment emulsions, aqueous emulsions, microemulsions, suspoemulsions, capsule suspensions, water soluble granules, fine granules, soluble concentrates, venoms, block baits, granular baits, tablet baits, concentrated baits, sustained release blocks, electrostatic sprays, oil-in-water emulsions, aerosol cans, aerosol candles, aerosol cartridges, aerosol sticks, aerosol tablets, aerosol pellets, gas generants, ointments, hot fogging formulations, cold fogging formulations, aerosols, solid/liquid mixtures, liquid/liquid mixtures, solid/solid mixtures, lacquers, microgranules, chasing powders, oil suspensions, oil dispersible powders, concentrated gels, pour-on formulations, seed coatings, paints, film-forming oils, ultra-low volume liquids, vapor release agents;
the plant insect pests controlled by the insecticidal composition are selected from: meadow spodoptera, red spider, east Asian migratory locust, spruce-bug, Chinese rice locust, japanese yellow-back locust, single-prick mole cricket, oriental mole cricket, rice thrips, thrips tabaci, green house thrips, rice straw thistle, wheat simple pipe thrips, green house whitefly, bemisia tabaci, black tail hopper, big leaf hopper, cotton leafhopper, lesser leafhopper, brown plant hopper, white back plant hopper, gray plant hopper, sugarcane flat leaf planthopper, cotton aphid, binary wheat aphid, wheat straw aphid, peach aphid, sorghum aphid, radish aphid, mealybug, lybug, stinkbug, arrowhead bug, round scale, white insect, red wax insect, red worm, mealybug, pear net, banana net bug, tiny flower bug, laceleaf fly, green fly, rice moth, black armyworm, black fly, black rice moth, black armyworm, black rice moth, black rice plant, black rice plant, black rice plant, green plant, rice plant, black rice plant, green plant, rice plant, green plant, rice plant, pink bollworm, sweet potato wheat moth, diamond back moth, peach fruit borer, soybean pod borer, peach fruit borer, apple tip leaf roller moth, brown banded leaf roller moth, pardos leaf roller moth, striped rice borer, pod borer, corn borer, yellow rice borer, cabbage moth, rice leaf roller borer, striped rice borer, cotton leaf borer, peach borer, armyworm, prodenia litura, rice bollworm, cotton small bridgehead moth, beet armyworm, sesamia inferen, cotton bollworm, Dinodon diamond-back moth, agrotis, yellow cutworm, robber venom moth, gypsy moth, sweet potato hawkmoth, bean hawkmoth, straight grain rice skipper, cryptophyte butterfly, caeruleuca, caeruleuciscus nigra, yellow mealyratus caeruleucade, yellow meadowrue, yellow rice beetle, yellow tiger, red ramie yellow vanne, yellow rice borer, yellow rice, yellow rice borer, yellow rice borer, yellow rice borer, yellow rice borer, yellow rice borer, yellow rice borer, yellow rice borer, yellow rice, yellow rice borer, yellow rice borer, yellow rice borer, yellow rice, yellow rice borer, yellow rice borer, yellow rice, yellow rice borer, yellow rice, Tribolium castaneum, verdigris, black tortoise, branchia palustris, longicorn beetle, pink neck longicorn beetle, ape leaf worm, yellow melon, flea beetle, mung bean weevil, pea weevil, broad bean weevil, corn weevil, rice weevil, wheat leaf bee, pear fruit bee, yellow stripe wasp, armyworm white star ichneumonid, sandfly bractenoconid, cotton bollworm tooth-lipped ichneumonid, borer black spot wart, mosquito, fly, horsefly, red mud fly, yellow leaf sucking serous, rice gall mosquito fly, citrus fruit fly, melon fruit fly, wheat leaf gray fly, American fly, black stalk black fly, wheat stem fly, seed fly, onion fly, radish skirt, eupatorium, corn borer, and armyworm;
the plants controlled by the insecticidal composition are selected from the following plants: rice, wheat, barley, oats, corn, sorghum, sweet potato, cassava, soybean, sweet broad bean, pea, mung bean, small bean, cotton, silkworm, peanut, rape, sesame, sunflower, sugar beet, sugarcane, coffee, cocoa, ginseng, fritillaria, rubber, coconut, oil palm, sisal, tobacco, tomato, chili, radish, cucumber, cabbage, celery, tuber mustard, sugar beet, rape, shallot, garlic, watermelon, melon, cantaloupe, papaya, apple, citrus and peach, tea, wild vegetables, bamboo shoots, hops, pepper, banana, papaya, orchid, bonsai.
The 1,3, 4-oxadiazole psoralen derivative I and any one or two of the bactericides are combined to form a bactericidal composition for preventing and treating diseases of agricultural, forestry and horticultural plants;
the bactericide is selected from: benzothiadiazole, tiadinil, thianamide, methicillin, 4-methyl-1, 2, 3-thiadiazole-5-carboxylic acid, 4-methyl-1, 2, 3-thiadiazole-5-sodium formate, 4-methyl-1, 2, 3-thiadiazole-5-ethyl formate, DL-beta-aminobutyric acid, isotianil, 3, 4-dichloroisothiazole-5-carboxylic acid, 3, 4-dichloroisothiazole-5-sodium formate, 3, 4-dichloroisothiazole-5-ethyl formate, ribavirin, antofine, ningnanmycin or salicylic acid, cyanamide, thiram, ziram, mancozeb, fosetyl, thiophanate-methyl, chlorothalonil, chlormadinone, procymidone, fenpropidium rust, Thiophanate methyl, thiophanate, metalaxyl-M, flumorph, dimethomorph, metalaxyl-M, benalaxyl-M, diclocyanamide, sulfentram, sulfsulfamide, thifluzamide, folpet, cyprodinil, cyhalodiamide, silthiopham, carboxin, oxim-methyl, mefuram, fenazamide, flutolanil, furametpyr, thifluzamide, boscalid, penthiopyrad, isopyrazamide, bixafen, fluopyram, fluxastrobin, fluxapyroxad, flufenapyr, benconazole, iprovalicarb, flutriafolan, flufenpyrazamide, flufenacetmid, fluoxastrobin, fenhexamid, iprodione, trifloxystrobin, kresoximtrobin, trifloxystrobin, fenstrobin, fenstrobilurin, fenpyraclostrobin, fluoxastrobin, fluoxastrobilurin, fluoxastrobin, fluoxastrobilurin, fluoxastrobin, fluoxastrobilurin, fluoxastrobin, fluoxastrobilurin, fluoxastrobin, fluoxastrobilurin, fluoxastrobin, fluopicolide, fluopicolinate, fluopicolide, fluopicolinate, fluopicolide, fluopicolinate, fluo, Enestroburin, dimethomorph, difenoconazole, bromhexine, epoxiconazole, bromuconazole, cyproconazole, difenoconazole, diniconazole, difenoconazole, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, penconazole, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimenol, triticonazole, bitertanol, thiabendazole, imazalil, prochloraz, triflumizole, cyazofamid, fenamidone, imidazole, pefurazoate, famoxadone, pyridinozole, prodiamine, ethaboxam, hymexazol, penoxsulam, fenthion, fenpropimorph, tridemorph, fenpyroxanil, fluazinam, fenpropiconazole, fenpyrazamide, fluazinam, cyprodinil, flufenamidone, fenpyrad, fenpyroxim, fenpyroxapyroxapyroxad, fenpyroxad-methyl, fenpyroxad-a, Mepanipyrim, pyrimethanil, fenarimol, fluoropyrimidinol, mefenamate, dithianon, ethoxyquin, hydroxyquinoline, propoxymine, phenoxyquinoline, diethofencarb, iprovalicarb, benthiavalicarb, propamocarb, sulbencarb, edifenphos, iprobenfos, pyrazofos, tolclofos-methyl, blasticidin, kasugamycin, polyoxin, validamycin, streptomycin, metalaxyl, furalaxyl, benomyl, thiophanate-methyl, triadimefon, bupirimate, dimethirimol, ethirimol, captan, folpet, vinclozolin, fluocinolone, dimethachlon, chlorothalonil, isoprothiolane, pefurazone, bismerzole, quintozene, propineb, fosetyl, sulfur, polidocusate, cuprous oxide, cupric chloride, cupric oxide, cupric hydroxide, Metrafenone, pencycuron, pyridaben, tetrachlorophthalide, pyroquilon, spiroxamine, tricyclazole, azinam, dodine, diguanidinium salt, diguanidinium, niclosamide, bentiamine, tolfenpyrad, indole ester, sodium disulfate, quinconazole, probenazole, bronopol, methyl iodide, metam, dichloline ester, dazomet, dichloroisopropyl ether, fosthiazate, fosfenthion, fenamiphos, thiothifenthion, methiocarb, sulfuryl fluoride, dichloropropylene, dichloroisonicotinic acid, allylisothiazole;
the 1,3, 4-oxadiazole psoralen derivative I accounts for 1-90% of the total mass of the sterilization composition; the proportion of the 1,3, 4-oxadiazole psoralen derivative I to the bactericide is 1 to 99 to 1 mass percent;
the bactericidal composition is processed into a dosage form selected from the group consisting of: seed treatment emulsions, aqueous emulsions, microemulsions, suspoemulsions, capsule suspensions, water soluble granules, fine granules, soluble concentrates, venoms, block baits, granular baits, tablet baits, concentrated baits, sustained release blocks, electrostatic sprays, oil-in-water emulsions, aerosol cans, aerosol candles, aerosol cartridges, aerosol sticks, aerosol tablets, aerosol pellets, gas generants, ointments, hot fogging formulations, cold fogging formulations, aerosols, solid/liquid mixtures, liquid/liquid mixtures, solid/solid mixtures, lacquers, microgranules, chasing powders, oil suspensions, oil dispersible powders, concentrated gels, pour-on formulations, seed coatings, paints, film-forming oils, ultra-low volume liquids, vapor release agents;
the plant diseases controlled by the bactericidal composition are selected from: rice seedling blight, tomato root rot, potato late blight, tobacco black shank, millet powdery mildew, grape downy mildew, lettuce downy mildew, cucumber anthracnose;
the plants suitable for the bactericidal composition are selected from the group consisting of: rice, wheat, barley, oats, corn, sorghum, sweet potato, cassava, soybean, sweet broad bean, pea, mung bean, small bean, cotton, silkworm, peanut, rape, sesame, sunflower, sugar beet, sugarcane, coffee, cocoa, ginseng, fritillaria, rubber, coconut, oil palm, sisal, tobacco, tomato, chili, radish, cucumber, cabbage, celery, tuber mustard, sugar beet, rape, shallot, garlic, watermelon, melon, cantaloupe, papaya, apple, citrus and peach, tea, wild vegetables, bamboo shoots, hops, pepper, banana, papaya, orchid, bonsai.
The 1,3, 4-oxadiazole psoralen derivative I and any one or two of the antiviral medicaments are combined to form an antiviral composition for preventing and treating virus diseases of agricultural and forestry and horticultural plants;
the antiviral agent is selected from: benzothiadiazole, tiadinil, isotianil, 4-methyl-1, 2, 3-thiadiazole-5-carboxylic acid, 4-methyl-1, 2, 3-thiadiazole-5-sodium formate, 4-methyl-1, 2, 3-thiadiazole-5-ethyl formate, 3, 4-dichloroisothiazole-5-carboxylic acid, 3, 4-dichloroisothiazole-5-sodium formate, 3, 4-dichloroisothiazole-5-ethyl formate, DL-beta-aminobutyric acid, 2, 6-dichloroisonicotinic acid, N-cyanomethyl-2-chloroisonicotinamide, probenazole, virazole, antofine, ningnanmycin, thiamide, methiothiamide or salicylic acid, pyriminomycin, Dichloroisonicotinic acid, probenazole, validamycin, moroxydine hydrochloride;
the 1,3, 4-oxadiazole psoralen derivative I accounts for 1-90% of the total mass of the antiviral composition; preferably, the ratio of the 1,3, 4-oxadiazole psoralen derivative I to the anti-plant virus agent is 1% to 99% to 1% in percentage by mass;
the antiviral composition is processed into a dosage form selected from: seed treatment emulsions, aqueous emulsions, microemulsions, suspoemulsions, capsule suspensions, water soluble granules, fine granules, soluble concentrates, venoms, block baits, granular baits, tablet baits, concentrated baits, sustained release blocks, electrostatic sprays, oil-in-water emulsions, aerosol cans, aerosol candles, aerosol cartridges, aerosol sticks, aerosol tablets, aerosol pellets, gas generants, ointments, hot fogging formulations, cold fogging formulations, aerosols, solid/liquid mixtures, liquid/liquid mixtures, solid/solid mixtures, lacquers, microgranules, chasing powders, oil suspensions, oil dispersible powders, concentrated gels, pour-on formulations, seed coatings, paints, film-forming oils, ultra-low volume liquids, vapor release agents;
the antiviral composition can be used for preventing and treating viral diseases selected from: rice dwarf, yellow dwarf, stripe disease, tomato fern leaf virus, pepper mosaic virus, tobacco vein necrosis virus, maize dwarf mosaic, cauliflower mosaic, citrus virus, cymbidium mosaic, cymbidium ringspot virus;
the plants for preventing and treating the antiviral composition are selected from the following plants: rice, wheat, barley, oats, corn, sorghum, sweet potato, cassava, soybean, sweet broad bean, pea, mung bean, small bean, cotton, silkworm, peanut, rape, sesame, sunflower, sugar beet, sugarcane, coffee, cocoa, ginseng, fritillaria, rubber, coconut, oil palm, sisal, tobacco, tomato, chili, radish, cucumber, cabbage, celery, tuber mustard, sugar beet, rape, shallot, garlic, watermelon, melon, cantaloupe, papaya, apple, citrus and peach, tea, wild vegetables, bamboo shoots, hops, pepper, banana, papaya, orchid, bonsai.
The 1,3, 4-oxadiazole psoralen derivative I and any one or two of acaricides are combined to form an acaricide composition for preventing and controlling mite damage of agricultural and forestry and horticultural plants;
the acaricide is selected from: dichlorvos, heptenophos, metofos, monocrotophos, phosphorus dibromide, pyrimidophos, chloromethylthion, ethion, chlorfenvinphos, vofenthion, pirimiphos, phoxim, isocarbophos, amicarbazone, chlormephos, fluthrin, bifenthrin, cyhalothrin, lambda-cyhalothrin, fenpropathrin, flumethrin, fluvalinate, bifenthrin, bifenazate, fenobucarb, butoxycarb, carbofuran, monocarb, benomyl, cloxacarb, butathiocarb, lufenuron, benzyl benzoate, bromopropylate, cyflumetofen, dimethrin, flufenpyr, fluazuron, bleomycin, chlortetracycline, abamectin, avermectin, lium, lividin, doramectin, epothidin, ivermectin, simethiofen, dimethofos, dimethrin, dimethoxim, fosetyl, chlorfenapyr, isofos, chlorfenapyr, dimethoxim, fluazurin, isomycin, chlorfenacin, avermectin, chlorfenacin, chlorfenapyr, chlorpyrifos, chlorpyri, Nicotine, matrine, azadirachtin, rotenone, tebufenpyrad, pyridaben, fenpyroximate, clofentezine, propargite, hexythiazox, spirodiclofen, fluacrypyrim, propargite and pyridaben;
the total mass percentage of the 1,3, 4-oxadiazole psoralen derivative I in the acaricidal composition is 1% -90%; the ratio of the 1,3, 4-oxadiazole psoralen derivative I to the acaricide is 1 to 99 to 1 percent by mass percent;
the acaricidal composition is processed into a dosage form selected from the following: seed treatment emulsions, aqueous emulsions, microemulsions, suspoemulsions, capsule suspensions, water soluble granules, fine granules, soluble concentrates, venoms, block baits, granular baits, tablet baits, concentrated baits, sustained release blocks, electrostatic sprays, oil-in-water emulsions, aerosol cans, aerosol candles, aerosol cartridges, aerosol sticks, aerosol tablets, aerosol pellets, gas generants, ointments, hot fogging formulations, cold fogging formulations, aerosols, solid/liquid mixtures, liquid/liquid mixtures, solid/solid mixtures, lacquers, microgranules, chasing powders, oil suspensions, oil dispersible powders, concentrated gels, pour-on formulations, seed coatings, paints, film-forming oils, ultra-low volume liquids, vapor release agents;
the mite damage controlled by the mite-killing composition is selected from the following groups: the mite is selected from spider mite family, furaciidae, gall mite family, Tetranychus genus, and pest mites of gall mite family, which are world agricultural pest mites, forestry pest mites, horticultural pest mites, and health pest mites;
the plant for controlling the acaricidal composition is selected from the following plants: rice, wheat, barley, oats, corn, sorghum, sweet potato, cassava, soybean, sweet broad bean, pea, mung bean, small bean, cotton, silkworm, peanut, rape, sesame, sunflower, sugar beet, sugarcane, coffee, cocoa, ginseng, fritillaria, rubber, coconut, oil palm, sisal, tobacco, tomato, chili, radish, cucumber, cabbage, celery, tuber mustard, sugar beet, rape, shallot, garlic, watermelon, melon, cantaloupe, papaya, apple, citrus and peach, tea, wild vegetables, bamboo shoots, hops, pepper, banana, papaya, orchid, bonsai.
The biological activity of the 1,3, 4-oxadiazole psoralen derivative I is determined as follows:
the bactericidal activity of the 1,3, 4-oxadiazole psoralen derivative I of the invention is determined as follows:
the bactericidal or bacteriostatic activity of the invention containing 1,3, 4-oxadiazole psoralen I adopts a thallus growth rate determination method, which comprises the following specific steps: dissolving 1.8 mg of sample in 2 drops of N, N-dimethylformamide, diluting with a water solution containing a certain amount of Tween 20 emulsifier to 500 micrograms/ml of medicament, sucking 1 ml of the medicament to be tested in a culture dish under an aseptic condition, adding 9 ml of PDA culture medium, shaking uniformly to prepare a medicament-containing flat plate with the concentration of 50 micrograms/ml, taking the flat plate added with 1 ml of sterile water as a blank control, cutting a bacterial disc by a puncher with the diameter of 4 mm along the outer edge of hypha, moving the bacterial disc to the medicament-containing flat plate, placing the bacterial disc in an equilateral triangle, repeating the treatment for 3 times, placing the culture dish in a constant temperature incubator with the temperature of 24 +/-1 ℃ for culture, investigating the expansion diameter of each treated bacterial disc after the diameter of the control bacterial colony is expanded to 2-3 cm, calculating the relative bacteriostasis rate by comparing with the blank control, wherein the strain is the species of most typical plant pathogenic bacteria actually occurring in the agricultural production of China, the code numbers and names are as follows: AS: tomato early blight, its latin name is: alternaria solani, BC: the cucumber botrytis cinerea with the latin name as follows: botrytis cinerea, CA: peanut brown spot pathogen, its latin name is: cercospora arachidicola, GZ: wheat scab, its latin name is: gibberella zeae, PP: apple ring rot, its latin name is: physiosporia piricola, PS: rhizoctonia solani, the Latin name of which is: pellicularia sasakii, SS: sclerotinia sclerotiorum, its latin name is: sclerotina sclerotiorum.
The invention has the beneficial effects that: the 1,3, 4-oxadiazole psoralen derivatives I are subjected to lead optimization, and the 1,3, 4-oxadiazole psoralen derivatives are subjected to antibacterial activity screening.
The synthesis, biological activity and application of 1,3, 4-oxadiazole psoralen derivatives I are more specifically illustrated by specific preparation and biological activity determination examples, which are only used for specifically illustrating the invention and not limiting the invention, in particular, the biological activity is only illustrated and not limiting the patent, and the specific implementation modes are as follows:
example 1: preparation of compound 3:
a100 ml round-bottom flask was charged with 18.2 mmol of resorcinol and 18.2 mmol of dimethyl acetylsuccinate, followed by slowly dropping 2.73 ml of 98% concentrated sulfuric acid under stirring, and after the dropping was completed, the reaction system was stirred at room temperature overnight. TLC monitoring, after the reaction was complete 30 ml of anhydrous methanol was added and poured into ice water to yield a large amount of white solid, the solid obtained was filtered off with suction, the crude product was washed with diethyl ether and taken in with ethanol-waterRecrystallizing to obtain a compound 3; the yield is 81%; the nuclear magnetic data are as follows:1h NMR (400MHz, DMSO) δ 10.50(s, 1H), 7.59(d, J ═ 8.8Hz, 1H), 6.79(dd, J ═ 8.7, 2.1Hz, 1H), 6.69(d, J ═ 2.1Hz, 1H), 3.61(s, 2H), 3.57(s, 3H), 2.30(s, 3H). The amount of compound 3 produced and the volume of the reaction vessel are scaled up or down accordingly.
Example 2: preparation of compound 5:
a100 ml round-bottom flask was charged with 1 mmol of Compound 3 and 30 ml of anhydrous acetonitrile, and 1.2 mmol of Compound 4, 4 mmol of anhydrous potassium carbonate and 0.1 mmol of potassium iodide were sequentially added under stirring at room temperature, followed by heating and refluxing the reaction system for 5 hours. Monitoring by TLC, standing and cooling to room temperature after the reaction is finished, removing most acetonitrile under reduced pressure, adding 30 ml of water into the residue, extracting for three times (15 ml. times.3) by using ethyl acetate, washing the organic phase for three times (15 ml. times.3) by using saturated sodium chloride solution, and drying the combined organic layers by using anhydrous sodium sulfate; vacuum filtering, concentrating the filtrate to remove solvent, and purifying with petroleum ether/ethyl acetate (3: 1, volume/volume) eluent column chromatography to obtain compound 5; the yield is 65%; the nuclear magnetic data are as follows:1h NMR (400MHz, DMSO) δ 8.12(s, 2H), 7.74(d, J ═ 8.8Hz, 1H), 7.42(t, J ═ 8.5Hz, 2H), 7.10(s, 1H), 7.04(d, J ═ 8.7Hz, 1H), 5.73(s, 2H), 3.67(s, 2H), 3.62(s, 3H), 2.38(s, 3H). The amount of compound 5 produced and the volume of the reaction vessel are scaled up or down accordingly.
Example 3: preparation of compound 6:
adding 2 g of compound 5 and 30 ml of isopropanol into a 100 ml round-bottom flask, slowly dropwise adding 60 ml of 1 mol/L sodium hydroxide solution at room temperature under stirring, heating and refluxing the reaction system for 4 hours after dropwise adding. Monitoring by TLC, standing the system after the reaction is finished, cooling to room temperature, removing most isopropanol under reduced pressure, adding 1 mol/L hydrochloric acid solution into the residue to adjust the pH of the system to 1, precipitating a large amount of solid, performing suction filtration, and drying to obtain a compound 6; the yield thereof was found to be 61%; the nuclear magnetic data are as follows:1h NMR (400MHz, DMSO). delta.12.29 (s, 1H), 8.30(s, 1H), 7.98(s, 1H), 7.70(s, 1H), 7.61(s, 1H), 7.22(s, 2H), 3.49(s, 2H), 2.36(s, 3H). The amount of compound 6 produced and the volume of the reaction vessel are scaled up or down accordingly.
Example 4: preparation of compound 7:
1 g of compound 6 and 30 ml of anhydrous methanol are added into a 100 ml round-bottom flask, 1.5 ml of 98% concentrated sulfuric acid is slowly dropped into the flask under stirring at room temperature, and the reaction system is heated and refluxed for 6 hours after the dropping is finished. TLC, after the reaction was complete, the system was allowed to stand to cool to room temperature, most of the methanol was removed under reduced pressure, 15 ml of water was added to the residue, extracted three times with ethyl acetate (15 ml × 3), the organic phase was washed three times with saturated sodium chloride solution (15 ml × 3), and the combined organic layers were dried over anhydrous sodium sulfate; vacuum filtering, concentrating the filtrate to remove solvent, and purifying with petroleum ether/ethyl acetate (3: 1, volume/volume) eluent column chromatography to obtain compound 7; the yield is 79 percent; the nuclear magnetic data are as follows:1h NMR (400MHz, DMSO) δ 8.47(s, 1H), 8.17(s, 1H), 7.87(dd, J ═ 8.7, 5.5Hz, 2H), 7.80(s, 1H), 7.38(t, J ═ 8.8Hz, 2H), 3.75(s, 2H), 3.63(s, 3H), 2.55(s, 3H). The amount of compound 7 produced and the volume of the reaction vessel are scaled up or down accordingly.
Example 5: preparation of compound 8:
a100 ml round-bottom flask was charged with 1 mmol of Compound 7 and 30 ml of methanol, and stirred at room temperature4 millimole of 80% hydrazine hydrate is slowly added dropwise, and the reaction system is heated and refluxed for 6 hours after the addition is finished. TLC, after the reaction was complete, the system was allowed to stand to cool to room temperature, most of the methanol was removed under reduced pressure, 15 ml of water was added to the residue, extracted three times with ethyl acetate (15 ml × 3), the organic phase was washed three times with saturated sodium chloride solution (15 ml × 3), and the combined organic layers were dried over anhydrous sodium sulfate; vacuum filtering, concentrating the filtrate to remove solvent, and purifying with dichloromethane/methanol (15: 1, volume/volume) eluent column chromatography to obtain compound 8; the yield is 53 percent; the nuclear magnetic data are as follows:1h NMR (400MHz, DMSO). delta.9.18 (s, 1H), 8.44(s, 1H), 8.09(s, 1H), 7.85(s, 2H), 7.73(s, 1H), 7.38(s, 2H), 4.30(s, 2H), 3.51(s, 2H), 3.41(s, 3H). The amount of compound 8 produced and the volume of the reaction vessel are scaled up or down accordingly.
Example 6: preparation of compound 9:
a100 ml round bottom flask was charged with 0.2 g of Compound 8 and 20 ml of absolute ethanol, 0.033 g of potassium hydroxide was added with stirring, after 5 minutes 0.11 g of carbon disulfide was added slowly, and the reaction was heated to reflux for 5 hours. Monitoring by TLC, after the reaction is finished, standing the system, cooling to room temperature, removing most ethanol under reduced pressure, adding 15 ml of water into the residue, adjusting the pH of the system to 1-2 by using 1 mol/l hydrochloric acid solution, extracting three times (15 ml × 3) by using ethyl acetate, washing three times (15 ml × 3) by using saturated sodium chloride solution for an organic phase, and drying combined organic layers by using anhydrous sodium sulfate; vacuum filtering, concentrating the filtrate to remove solvent, and purifying with dichloromethane/methanol (17: 1, volume/volume) eluent column chromatography to obtain compound 9; the yield is 77%; the nuclear magnetic data are as follows:1h NMR (400MHz, DMSO) δ 14.40(s, 1H), 8.47(s, 1H), 8.18(s, 1H), 7.89-7.83(m, 2H), 7.80(s, 1H), 7.37(t, J ═ 8.6Hz, 2H), 4.15(s, 2H), 2.63(s, 3H). The amount of compound 9 produced and the volume of the reaction vessel are scaled up or down accordingly.
Example 7: preparation of Compound I-a:
a100 ml round-bottom flask was charged with 0.2 g of Compound 9 and 20 ml of N, N-dimethylformamide, and 0.063 g of potassium hydroxide and 0.175 g of 4-iodobenzyl bromide were successively added under stirring, followed by stirring the system at room temperature for 8 hours. TLC, 30 ml of water was added after the reaction was complete, extracted three times with ethyl acetate (15 ml × 3), the organic phase was washed three times with saturated sodium chloride solution (15 ml × 3), and the combined organic layers were dried over anhydrous sodium sulfate; vacuum filtering, concentrating the filtrate to remove solvent, and purifying with dichloromethane/methanol (30: 1, volume/volume) eluent column chromatography to obtain compound I-a; yield: 71-95 percent; when R is1Is 4-fluorophenyl, R2For 4-iodobenzyl, the nuclear magnetic data for compound I-a-1 is as follows:1h NMR (400MHz, DMSO) δ 8.40(s, 1H), 8.09(s, 1H), 7.84-7.77(m, 2H), 7.70(s, 1H), 7.55(d, J ═ 7.9Hz, 2H), 7.33(t, J ═ 8.6Hz, 2H), 7.15(d, J ═ 7.9Hz, 2H), 4.37(s, 2H), 4.22(s, 2H), 2.56(s, 3H). The preparation amount of the compound I-a-1 and the volume of a reaction vessel are enlarged or reduced according to corresponding proportion; the physicochemical and structural parameters of compound I-a are shown in Table 1.
Example 8: preparation of Compound I-b:
0.58 g of Compound I-a-1 and 20 ml of methylene chloride were placed in a 100 ml round-bottomed flask in a cold ice bath, 0.256 g of m-chloroperoxybenzoic acid was slowly added with stirring, and the reaction was allowed to stand at room temperature for 6 hours. TLC, after completion of the reaction most of the dichloromethane was removed under reduced pressure, extracted three times with ethyl acetate (15 ml × 3), the organic phase was washed three times with 0.25 mol/l disodium hydrogen phosphate solution (15 ml × 3) and saturated sodium chloride solution (15 ml × 3) in sequence, and the combined organic layers were dried over anhydrous sodium sulfate; reducingPerforming pressure suction filtration, concentrating the filtrate to remove the solvent, and performing column chromatography purification by using dichloromethane/methanol (40: 1, volume/volume) eluent to obtain a compound I-b; yield: 65-91%; when R1 is 4-fluorophenyl, R2For 4-iodobenzyl, the nuclear magnetic data for compound I-b-1 is as follows:1h NMR (400MHz, DMSO) δ 8.45(s, 1H), 8.17(s, 1H), 7.84(dd, J ═ 8.2, 5.5Hz, 2H), 7.79(s, 1H), 7.63(d, J ═ 8.1Hz, 2H), 7.36(t, J ═ 8.7Hz, 2H), 7.01(d, J ═ 8.0Hz, 2H), 4.68(q, J ═ 12.7Hz, 2H), 4.39(s, 2H), 2.63(s, 3H). The preparation amount of the compound I-b-1 and the volume of a reaction vessel are enlarged or reduced according to corresponding proportion; the physicochemical and structural parameters of the compounds I-b are shown in Table 1.
Example 9: preparation of Compounds I-c:
under the condition of low-temperature ice bath, 0.1 g of compound I-a-2 and 15 ml of anhydrous acetic acid are added into a 100 ml round-bottom flask, 10.7 ml of 30% hydrogen peroxide solution dissolved with 2 mg of ammonium molybdate is slowly dropped into the flask under stirring, and then the reaction system is moved to room temperature for reaction for 8 hours. TLC, 15 ml of water was added after the reaction was complete, extraction was performed three times with ethyl acetate (15 ml × 3), the organic phase was washed three times with saturated sodium hydrogen sulfate solution (15 ml × 3) and saturated sodium chloride solution (15 ml × 3) in sequence, and the combined organic layers were dried over anhydrous sodium sulfate; vacuum filtering, concentrating the filtrate to remove solvent, and purifying with dichloromethane/methanol (20: 1, volume/volume) eluent column chromatography to obtain compound I-c; yield: 93 percent; when R is1Is phenyl, R2In the case of 4-trifluoromethoxybenzyl group, the nuclear magnetic data of compound I-c-1 are as follows:1h NMR (400MHz, DMSO) δ 8.51(s, 1H), 8.27(s, 1H), 7.87-7.81(m, 3H), 7.55(t, J ═ 7.5Hz, 2H), 7.46-7.41(m, 3H), 7.31(d, J ═ 8.1Hz, 2H), 5.25(s, 2H), 4.41(s, 2H), 2.65(s, 3H). The preparation amount of the compound I-c-1 and the volume of a reaction vessel are enlarged or reduced according to corresponding proportion; the physicochemical and structural parameters of the compounds I-c are shown in Table 1.
Example 10: the antibacterial activity determination result of the 1,3, 4-oxadiazole psoralen derivative I provided by the invention is as follows:
the codes and names of the common plant pathogenic fungi tested by the invention are as follows: a.s: tomato early blight, its latin name is: alternaria solani, b.c: the cucumber botrytis cinerea with the latin name as follows: botrytis cinerea, C.a: peanut brown spot pathogen, its latin name is: cercospora arachidicola, G.z: wheat scab, its latin name is: gibberella zeae, P.p: apple ring rot, its latin name is: physiosporia piricola, P.s: rhizoctonia solani, the Latin name of which is: pellicularia sasakii, S.s: sclerotinia sclerotiorum, its latin name is: the strains have good representativeness and can represent the species of most pathogenic bacteria in the field in agricultural production.
The results of the cell growth rate method are shown in Table 2, and Table 2 shows that all the compounds synthesized by the invention have bactericidal activity of different degrees at 50 micrograms/ml. For tomato early blight bacteria, the inhibition rates of the compounds DJY-2-105, DJY-2-160, DJY-2-173, DJY-2-180, DJY-2-192, DJY-2-194, DJY-2-176 and DJY-2-200 are more than 65 percent and are all higher than 2210 percent of the control medicine bone lipid and YZK-C; for botrytis cinerea, the inhibition rates of the compounds DJY-2-160, DJY-2-174, DJY-2-170, DJY-2-178, DJY-2-184, DJY-2-176, DJY-2-199 and DJY-2-200 are more than 75%, the inhibition rates are superior to the control drugs of the bone lipid supplement and YZK-C22, especially the bactericidal activities of the compounds DJY-2-174, DJY-2-170 and DJY-2-176 are higher than 95%, and are higher than the control drugs of the bone lipid supplement and YZK-C2220%; for peanut brown spot pathogen, the inhibition rate of the compounds DJY-2-106, DJY-2-160, DJY-2-174 and DJY-2-127 is more than 70%, and is equal to or higher than that of a control medicament such as the bone lipid supplement drug and YZK-C22, wherein the bactericidal activity of the compound DJY-2-160 is the highest and reaches 88%, and is more than 20% higher than that of the control medicament such as the bone lipid supplement drug; for Gibberella tritici, the inhibition rates of the compounds DJY-2-105, DJY-2-112, DJY-2-129, DJY-2-160, DJY-2-168, DJY-2-173, DJY-2-174, DJY-2-192 and DJY-2-200 are more than 60 percent, and are equal to or higher than that of the control drugs for supplementing the bone lipoid and YZYZK-C22, wherein the inhibition rates of the compounds DJY-2-105, DJY-2-160 and DJY-2-168 are higher than that of the control drugs for supplementing the bone lipoid by nearly 10 percent; for apple ring spot bacteria, the inhibition rates of the compounds DJY-2-117, DJY-2-160, DJY-2-169, DJY-2-173, DJY-2-171, DJY-2-174, DJY-2-180 and DJY-2-192 are all over 60 percent and are over 20 percent higher than that of the control drug for supplementing the osteoproliferatin; for rhizoctonia solani, the inhibition rate of the compounds DKY-2-160 and DKY-2-192 is more than 70 percent and is more than 20 percent higher than that of a control medicament for supplementing the osseointegration; for Sclerotinia sclerotiorum, the inhibition rates of the compounds DJY-2-160, DJY-2-174, DJY-2-192 and DJY-2-194 are more than 65% and are better than the inhibition rates of the control drug-containing osteoproliferation and YZK-C22, wherein the inhibition rates of the compounds DJY-2-174, DJY-2-192 and DJY-2-194 are all higher than the inhibition rates of the control drug-containing osteoproliferation by more than 10%.
Example 11: the application of the 1,3, 4-oxadiazole psoralen derivative I in preparing the pesticide composition comprises the following steps:
the 1,3, 4-oxadiazole psoralen derivative I is used for preparing a pesticide composition, the composition contains the 1,3, 4-oxadiazole psoralen derivative I and an intermediate thereof as active ingredients, and the active ingredients are 0.1 to 99.9 weight percent, 99.9 to 0.1 weight percent of solid or liquid auxiliary agents and optionally 0 to 50 weight percent of surfactant.
Example 12: the application of the 1,3, 4-oxadiazole psoralen derivative I in preparing the pesticide compound composition comprises the following steps:
the 1,3, 4-oxadiazol psoralen derivative I and the intermediate thereof can be compounded with other commercial pesticides, namely insecticides, acaricides, bactericides, antiviral agents or plant activators to prepare a pesticide compound composition, the compound composition comprises the 1,3, 4-oxadiazol psoralen derivative I and the intermediate thereof and other commercial pesticides, namely insecticides, acaricides, bactericides, antiviral agents or plant activators, which are taken as active ingredients, the ratio of the 1,3, 4-oxadiazol psoralen derivative I and the intermediate thereof to other commercial pesticides, namely insecticides, acaricides, bactericides, antiviral agents or plant activators is 1 percent to 99 percent to 1 percent by mass, the content of the active ingredients is 0.1 to 99.9 percent by weight, and the solid or liquid auxiliary agents of 99.9 to 0.1 percent by weight, and optionally from 0 to 50% by weight of a surfactant.
Example 13: the application of the combination of the 1,3, 4-oxadiazole psoralen derivative I and the insecticide in preventing and treating agricultural, forestry and horticultural plant insect pests:
the 1,3, 4-oxadiazole psoralen derivative I and any one or two of commercial insecticides are combined to form an insecticidal composition for preventing and treating agricultural and forestry and horticultural plant insect pests, wherein the commercial insecticide is selected from the following components: methoprene, diazinon, acetamiprid, emamectin benzoate, milbemectin, abamectin, pleocidin, metaflumethrin, meperfluthrin, cyfluthrin, beta-cypermethrin, lambda-cyhalothrin, permethrin, allethrin, bifenthrin, permethrin, flumethrin, cyfluthrin, imidacloprid, nitenpyram, imidaclothianidin, thiacloprid, thiamethoxam, clothianidin, dinotefuran, cotinine, dinotefuran, diflubenzuron, chlorbenzuron, tefluazuron, flufenoxuron, lufenuron, chlorflufenoxuron, fluazuron, diflubenzuron, fluazuron, tezine, fluazuron, tezine, teflufenozide, tebufenozide, tezine, flufenozide, tebufenozide, tezine, tebufenozide, tezine, tebufenozide, tezine, tebufalin, tezine, tebenflumetsulbenflumetsulbens, tezine, tebenil, tezine, tebenil, tebenflumetsulbens, tebenil, tebens, tezine, tebens, and tebens, and the like, Methoxyfenozide, chromafenozide, dichlorvos, quinalphos, pyridaphenthion, cicada powder, carbaryl, pirimicarb, metolcarb, isoprocarb, cartap, fenobucarb, tetrafenozide, fenitrothion, hexythiazox, carbaryl, fenisobromolate, hexythiazox, pyridate, clofentezine, spirodiclofen, spirotetramat, azocyclobutazine, buprofezin, monosultap, dimehypo, chlorantraniliprole, tetrachlorantranilide, flubendiamide, cyantraniliprole, butenenitrile, tolfenpyrad, chlorfenapyr, pyrazofos, pyrazinone, etoxazole, tebufenpyrad, pyridaben, emamectin, and pentapyraflufen; the mass percentage of the 1,3, 4-oxadiazole psoralen derivative I in the insecticidal composition is 1-90%, and the mass percentage of the 1,3, 4-oxadiazole psoralen derivative I in the invention and the commercial insecticide is 1: 99-99: 1%; the insecticide composition is processed into a dosage form selected from the group consisting of: seed treatment emulsions, aqueous emulsions, microemulsions, suspoemulsions, capsule suspensions, water soluble granules, fine granules, soluble concentrates, venoms, block baits, granular baits, tablet baits, concentrated baits, sustained release blocks, electrostatic sprays, oil-in-water emulsions, aerosol cans, aerosol candles, aerosol cartridges, aerosol sticks, aerosol tablets, aerosol pellets, gas generants, ointments, hot fogging formulations, cold fogging formulations, aerosols, solid/liquid mixtures, liquid/liquid mixtures, solid/solid mixtures, lacquers, microgranules, chasing powders, oil suspensions, oil dispersible powders, concentrated gels, pour-on formulations, seed coatings, paints, film-forming oils, ultra-low volume liquids, vapor release agents; the plant insect pests controlled by the insecticidal composition are selected from: meadow spodoptera, red spider, east Asian migratory locust, spruce-bug, Chinese rice locust, japanese yellow-back locust, single-prick mole cricket, oriental mole cricket, rice thrips, thrips tabaci, green house thrips, rice straw thistle, wheat simple pipe thrips, green house whitefly, bemisia tabaci, black tail hopper, big leaf hopper, cotton leafhopper, lesser leafhopper, brown plant hopper, white back plant hopper, gray plant hopper, sugarcane flat leaf planthopper, cotton aphid, binary wheat aphid, wheat straw aphid, peach aphid, sorghum aphid, radish aphid, mealybug, lybug, stinkbug, arrowhead bug, round scale, white insect, red wax insect, red worm, mealybug, pear net, banana net bug, tiny flower bug, laceleaf fly, green fly, rice moth, black armyworm, black fly, black rice moth, black armyworm, black rice moth, black rice plant, black rice plant, black rice plant, green plant, rice plant, black rice plant, green plant, rice plant, green plant, rice plant, pink bollworm, sweet potato wheat moth, diamond back moth, peach fruit borer, soybean pod borer, peach fruit borer, apple tip leaf roller moth, brown banded leaf roller moth, pardos leaf roller moth, striped rice borer, pod borer, corn borer, yellow rice borer, cabbage moth, rice leaf roller borer, striped rice borer, cotton leaf borer, peach borer, armyworm, prodenia litura, rice bollworm, cotton small bridgehead moth, beet armyworm, sesamia inferen, cotton bollworm, Dinodon diamond-back moth, agrotis, yellow cutworm, robber venom moth, gypsy moth, sweet potato hawkmoth, bean hawkmoth, straight grain rice skipper, cryptophyte butterfly, caeruleuca, caeruleuciscus nigra, yellow mealyratus caeruleucade, yellow meadowrue, yellow rice beetle, yellow tiger, red ramie yellow vanne, yellow rice borer, yellow rice, yellow rice borer, yellow rice borer, yellow rice borer, yellow rice borer, yellow rice borer, yellow rice borer, yellow rice borer, yellow rice, yellow rice borer, yellow rice borer, yellow rice borer, yellow rice, yellow rice borer, yellow rice borer, yellow rice, yellow rice borer, yellow rice, Tribolium castaneum, verdigris, black tortoise, branchia palustris, longicorn beetle, pink neck longicorn beetle, ape leaf worm, yellow melon, flea beetle, mung bean weevil, pea weevil, broad bean weevil, corn weevil, rice weevil, wheat leaf bee, pear fruit bee, yellow stripe wasp, armyworm white star ichneumonid, sandfly bractenoconid, cotton bollworm tooth-lipped ichneumonid, borer black spot wart, mosquito, fly, horsefly, red mud fly, yellow leaf sucking serous, rice gall mosquito fly, citrus fruit fly, melon fruit fly, wheat leaf gray fly, American fly, black stalk black fly, wheat stem fly, seed fly, onion fly, radish skirt, eupatorium, corn borer, and armyworm; the plants controlled by the insecticidal composition are selected from the following plants: rice, wheat, barley, oats, corn, sorghum, sweet potato, cassava, soybean, sweet broad bean, pea, mung bean, small bean, cotton, silkworm, peanut, rape, sesame, sunflower, sugar beet, sugarcane, coffee, cocoa, ginseng, fritillaria, rubber, coconut, oil palm, sisal, tobacco, tomato, chili, radish, cucumber, cabbage, celery, tuber mustard, sugar beet, rape, shallot, garlic, watermelon, melon, cantaloupe, papaya, apple, citrus and peach, tea, wild vegetables, bamboo shoots, hops, pepper, banana, papaya, orchid, bonsai.
Example 14: the application of the combination of the 1,3, 4-oxadiazole psoralen derivative I and the bactericide in preventing and treating agricultural, forestry and horticultural plant diseases:
the 1,3, 4-oxadiazole psoralen derivative I and any one or two of commercial bactericides are combined to form a bactericidal composition for preventing and treating diseases of agricultural, forestry and horticultural plants, wherein the commercial bactericides are selected from the following group: benzothiadiazole, tiadinil, thianamide, methicillin, 4-methyl-1, 2, 3-thiadiazole-5-carboxylic acid, 4-methyl-1, 2, 3-thiadiazole-5-sodium formate, 4-methyl-1, 2, 3-thiadiazole-5-ethyl formate, DL-beta-aminobutyric acid, isotianil, 3, 4-dichloroisothiazole-5-carboxylic acid, 3, 4-dichloroisothiazole-5-sodium formate, 3, 4-dichloroisothiazole-5-ethyl formate, ribavirin, antofine, ningnanmycin or salicylic acid, cyanamide, thiram, ziram, mancozeb, fosetyl, thiophanate-methyl, chlorothalonil, chlormadinone, procymidone, fenpropidium rust, Thiophanate methyl, thiophanate, metalaxyl-M, flumorph, dimethomorph, metalaxyl-M, benalaxyl-M, diclocyanamide, sulfentram, sulfsulfamide, thifluzamide, folpet, cyprodinil, cyhalodiamide, silthiopham, carboxin, oxim-methyl, mefuram, fenazamide, flutolanil, furametpyr, thifluzamide, boscalid, penthiopyrad, isopyrazamide, bixafen, fluopyram, fluxastrobin, fluxapyroxad, flufenapyr, benconazole, iprovalicarb, flutriafolan, flufenpyrazamide, flufenacetmid, fluoxastrobin, fenhexamid, iprodione, trifloxystrobin, kresoximtrobin, trifloxystrobin, fenstrobin, fenstrobilurin, fenpyraclostrobin, fluoxastrobin, fluoxastrobilurin, fluoxastrobin, fluoxastrobilurin, fluoxastrobin, fluoxastrobilurin, fluoxastrobin, fluoxastrobilurin, fluoxastrobin, fluoxastrobilurin, fluoxastrobin, fluopicolide, fluopicolinate, fluopicolide, fluopicolinate, fluopicolide, fluopicolinate, fluo, Enestroburin, dimethomorph, difenoconazole, bromhexine, epoxiconazole, bromuconazole, cyproconazole, difenoconazole, diniconazole, difenoconazole, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, penconazole, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimenol, triticonazole, bitertanol, thiabendazole, imazalil, prochloraz, triflumizole, cyazofamid, fenamidone, imidazole, pefurazoate, famoxadone, pyridinozole, prodiamine, ethaboxam, hymexazol, penoxsulam, fenthion, fenpropimorph, tridemorph, fenpyroxanil, fluazinam, fenpropiconazole, fenpyrazamide, fluazinam, cyprodinil, flufenamidone, fenpyrad, fenpyroxim, fenpyroxapyroxapyroxad, fenpyroxad-methyl, fenpyroxad-a, Mepanipyrim, pyrimethanil, fenarimol, fluoropyrimidinol, mefenamate, dithianon, ethoxyquin, hydroxyquinoline, propoxymine, phenoxyquinoline, diethofencarb, iprovalicarb, benthiavalicarb, propamocarb, sulbencarb, edifenphos, iprobenfos, pyrazofos, tolclofos-methyl, blasticidin, kasugamycin, polyoxin, validamycin, streptomycin, metalaxyl, furalaxyl, benomyl, thiophanate-methyl, triadimefon, bupirimate, dimethirimol, ethirimol, captan, folpet, vinclozolin, fluocinolone, dimethachlon, chlorothalonil, isoprothiolane, pefurazone, bismerzole, quintozene, propineb, fosetyl, sulfur, polidocusate, cuprous oxide, cupric chloride, cupric oxide, cupric hydroxide, Metrafenone, pencycuron, pyridaben, tetrachlorophthalide, pyroquilon, spiroxamine, tricyclazole, azinam, dodine, diguanidinium salt, diguanidinium, niclosamide, bentiamine, tolfenpyrad, indole ester, sodium disulfate, quinconazole, probenazole, bronopol, methyl iodide, metam, dichloline ester, dazomet, dichloroisopropyl ether, fosthiazate, fosfenthion, fenamiphos, thiothifenthion, methiocarb, sulfuryl fluoride, dichloropropylene, dichloroisonicotinic acid, allylisothiazole; the total mass percentage of the 1,3, 4-oxadiazole psoralen derivative I in the sterilization composition is 1-90%, and the mass percentage of the 1,3, 4-oxadiazole psoralen derivative I in the sterilization composition to the commercial bactericide is 1: 99-99: 1%; the bactericidal composition is processed into a dosage form selected from the group consisting of: seed treatment emulsions, aqueous emulsions, microemulsions, suspoemulsions, capsule suspensions, water soluble granules, fine granules, soluble concentrates, venoms, block baits, granular baits, tablet baits, concentrated baits, sustained release blocks, electrostatic sprays, oil-in-water emulsions, aerosol cans, aerosol candles, aerosol cartridges, aerosol sticks, aerosol tablets, aerosol pellets, gas generants, ointments, hot fogging formulations, cold fogging formulations, aerosols, solid/liquid mixtures, liquid/liquid mixtures, solid/solid mixtures, lacquers, microgranules, chasing powders, oil suspensions, oil dispersible powders, concentrated gels, pour-on formulations, seed coatings, paints, film-forming oils, ultra-low volume liquids, vapor release agents; the plant diseases controlled by the bactericidal composition are selected from: rice seedling blight, tomato root rot, potato late blight, tobacco black shank, millet powdery mildew, grape downy mildew, lettuce downy mildew, cucumber anthracnose; the plants suitable for the bactericidal composition are selected from the group consisting of: rice, wheat, barley, oats, corn, sorghum, sweet potato, cassava, soybean, sweet broad bean, pea, mung bean, small bean, cotton, silkworm, peanut, rape, sesame, sunflower, sugar beet, sugarcane, coffee, cocoa, ginseng, fritillaria, rubber, coconut, oil palm, sisal, tobacco, tomato, chili, radish, cucumber, cabbage, celery, tuber mustard, sugar beet, rape, shallot, garlic, watermelon, melon, cantaloupe, papaya, apple, citrus and peach, tea, wild vegetables, bamboo shoots, hops, pepper, banana, papaya, orchid, bonsai.
Example 15-use of 1,3, 4-oxadiazolidvachellin derivatives I of the present invention in combination with an anti-plant virus agent for the control of viral diseases in agricultural and forestry and horticultural plants:
the 1,3, 4-oxadiazole psoralen derivative I and any one or two of commercial antiviral medicaments form an antiviral composition for preventing and treating viral diseases of agricultural, forestry and horticultural plants, wherein the commercial antiviral medicament is selected from the following components: benzothiadiazole, tiadinil, isotianil, 4-methyl-1, 2, 3-thiadiazole-5-carboxylic acid, 4-methyl-1, 2, 3-thiadiazole-5-sodium formate, 4-methyl-1, 2, 3-thiadiazole-5-ethyl formate, 3, 4-dichloroisothiazole-5-carboxylic acid, 3, 4-dichloroisothiazole-5-sodium formate, 3, 4-dichloroisothiazole-5-ethyl formate, DL-beta-aminobutyric acid, ribavirin, antofine, ningnanmycin, thiaamide, mehtothiazolamide or salicylic acid, pyriminomycin, dichloroisonicotinic acid, probenazole, validamycin hydrochloride; the 1,3, 4-oxadiazole psoralen derivative I accounts for 1-90% of the total mass of the antiviral composition, and the ratio of the 1,3, 4-oxadiazole psoralen derivative I to the commercial anti-plant virus agent accounts for 1-99-1% of the mass; the antiviral composition is processed into a dosage form selected from: seed treatment emulsions, aqueous emulsions, microemulsions, suspoemulsions, capsule suspensions, water soluble granules, fine granules, soluble concentrates, venoms, block baits, granular baits, tablet baits, concentrated baits, sustained release blocks, electrostatic sprays, oil-in-water emulsions, aerosol cans, aerosol candles, aerosol cartridges, aerosol sticks, aerosol tablets, aerosol pellets, gas generants, ointments, hot fogging formulations, cold fogging formulations, aerosols, solid/liquid mixtures, liquid/liquid mixtures, solid/solid mixtures, lacquers, microgranules, chasing powders, oil suspensions, oil dispersible powders, concentrated gels, pour-on formulations, seed coatings, paints, film-forming oils, ultra-low volume liquids, vapor release agents; the antiviral composition can be used for preventing and treating viral diseases selected from: rice dwarf, yellow dwarf, stripe disease, tomato fern leaf virus, pepper mosaic virus, tobacco vein necrosis virus, maize dwarf mosaic, cauliflower mosaic, citrus virus, cymbidium mosaic, cymbidium ringspot virus; the plants for preventing and treating the antiviral composition are selected from the following plants: rice, wheat, barley, oats, corn, sorghum, sweet potato, cassava, soybean, sweet broad bean, pea, mung bean, small bean, cotton, silkworm, peanut, rape, sesame, sunflower, sugar beet, sugarcane, coffee, cocoa, ginseng, fritillaria, rubber, coconut, oil palm, sisal, tobacco, tomato, chili, radish, cucumber, cabbage, celery, tuber mustard, sugar beet, rape, shallot, garlic, watermelon, melon, cantaloupe, papaya, apple, citrus and peach, tea, wild vegetables, bamboo shoots, hops, pepper, banana, papaya, orchid, bonsai.
Example 16: the application of the combination of the 1,3, 4-oxadiazole psoralen derivative I and the acaricide in preventing and controlling the mite damage of agricultural, forestry and horticultural plants is as follows:
the 1,3, 4-oxadiazole psoralen derivative I and any one or two of commercial acaricides form an acaricidal composition for preventing and controlling acarids of agricultural and forestry and horticultural plants, wherein the commercial acaricides are selected from the following groups: dichlorvos, heptenophos, metofos, monocrotophos, phosphorus dibromide, pyrimidophos, chloromethylthion, ethion, chlorfenvinphos, vofenthion, pirimiphos, phoxim, isocarbophos, amicarbazone, chlormephos, fluthrin, bifenthrin, cyhalothrin, lambda-cyhalothrin, fenpropathrin, flumethrin, fluvalinate, bifenthrin, bifenazate, fenobucarb, butoxycarb, carbofuran, monocarb, benomyl, cloxacarb, butathiocarb, lufenuron, benzyl benzoate, bromopropylate, cyflumetofen, dimethrin, flufenpyr, fluazuron, bleomycin, chlortetracycline, abamectin, avermectin, lium, lividin, doramectin, epothidin, ivermectin, simethiofen, dimethofos, dimethrin, dimethoxim, fosetyl, chlorfenapyr, isofos, chlorfenapyr, dimethoxim, fluazurin, isomycin, chlorfenacin, avermectin, chlorfenacin, chlorfenapyr, chlorpyrifos, chlorpyri, Nicotine, matrine, azadirachtin, rotenone, tebufenpyrad, pyridaben, fenpyroximate, clofentezine, propargite, hexythiazox, spirodiclofen, fluacrypyrim, propargite and pyridaben; the total mass percentage of the 1,3, 4-oxadiazole psoralen derivative I in the acaricidal composition is 1-90%, and the mass percentage of the 1,3, 4-oxadiazole psoralen derivative I in the invention to the commercial acaricide is 1: 99-99: 1%; the acaricidal composition is processed into a dosage form selected from the following: seed treatment emulsions, aqueous emulsions, microemulsions, suspoemulsions, capsule suspensions, water soluble granules, fine granules, soluble concentrates, venoms, block baits, granular baits, tablet baits, concentrated baits, sustained release blocks, electrostatic sprays, oil-in-water emulsions, aerosol cans, aerosol candles, aerosol cartridges, aerosol sticks, aerosol tablets, aerosol pellets, gas generants, ointments, hot fogging formulations, cold fogging formulations, aerosols, solid/liquid mixtures, liquid/liquid mixtures, solid/solid mixtures, lacquers, microgranules, chasing powders, oil suspensions, oil dispersible powders, concentrated gels, pour-on formulations, seed coatings, paints, film-forming oils, ultra-low volume liquids, vapor release agents; the mite damage controlled by the mite-killing composition is selected from the following groups: the mite is selected from spider mite family, furaciidae, goiter family, Tetranychus genus, and pest mites of the goiter family, which are world agricultural pest mites, forestry pest mites, horticultural pest mites, and health pest mites; the plant for controlling the acaricidal composition is selected from the following plants: rice, wheat, barley, oats, corn, sorghum, sweet potato, cassava, soybean, sweet broad bean, pea, mung bean, small bean, cotton, silkworm, peanut, rape, sesame, sunflower, sugar beet, sugarcane, coffee, cocoa, ginseng, fritillaria, rubber, coconut, oil palm, sisal, tobacco, tomato, chili, radish, cucumber, cabbage, celery, tuber mustard, sugar beet, rape, shallot, garlic, watermelon, melon, cantaloupe, papaya, apple, citrus and peach, tea, wild vegetables, bamboo shoots, hops, pepper, banana, papaya, orchid, bonsai.
Industrial applicability
The invention provides 1,3, 4-oxadiazole psoralen derivatives; the derivative can regulate and control the biological activity of agricultural, horticultural and sanitary pests and plant pathogens of forestry plants, can be used for killing insects, killing mites, sterilizing, resisting plant viruses and inducing plants to generate disease resistance in the agricultural field, the horticultural field and the forestry field, and has better economic value and application prospect.
TABLE 2 antibacterial Activity of 1,3, 4-oxadiazolpsoralen derivatives I of the present invention (inhibition rate of 50. mu.g/ml/%)
Serial number | Compound (I) | A.s | B.c | C.a | G.z | P.p | P.s | S.s |
1 | DJY-2-103 | 64 | 45 | 30 | 39 | 32 | 17 | 44 |
2 | DJY-2-104 | 60 | 31 | 28 | 48 | 21 | 21 | 37 |
3 | DJY-2-105 | 78 | 42 | 17 | 75 | 15 | 28 | 33 |
4 | DJY-2-106 | 63 | 29 | 72 | 29 | 5 | 36 | 61 |
5 | DJY-2-107 | 57 | 40 | 24 | 52 | 38 | 24 | 24 |
6 | DJY-2-109 | 64 | 39 | 14 | 52 | 21 | 21 | 35 |
7 | DJY-2-111 | 63 | 47 | 37 | 45 | 38 | 15 | 43 |
8 | DJY-2-112 | 58 | 49 | 31 | 70 | 25 | 25 | 57 |
9 | DJY-2-114 | 56 | 58 | 47 | 40 | 43 | 21 | 60 |
10 | DJY-2-115 | 44 | 55 | 21 | 49 | 19 | 13 | 45 |
11 | DJY-2-117 | 47 | 42 | 48 | 46 | 76 | 17 | 35 |
12 | DJY-2-123 | 34 | 34 | 29 | 56 | 28 | 18 | 46 |
13 | DJY-2-121 | 59 | 50 | 38 | 24 | 24 | 9 | 52 |
14 | DJY-2-129 | 43 | 47 | 38 | 61 | 12 | 11 | 55 |
15 | DJY-2-120 | 65 | 41 | 21 | 29 | 32 | 26 | 47 |
16 | DJY-2-116 | 38 | 73 | 19 | 34 | 11 | 22 | 39 |
17 | DJY-2-108 | 57 | 43 | 35 | 25 | 26 | 24 | 53 |
18 | DJY-2-160 | 89 | 85 | 88 | 73 | 77 | 77 | 65 |
19 | DJY-2-168 | 65 | 58 | 59 | 72 | 53 | 38 | 55 |
20 | DJY-2-169 | 63 | 42 | 64 | 52 | 63 | 53 | 59 |
21 | DJY-2-173 | 75 | 49 | 63 | 67 | 75 | 23 | 62 |
22 | DJY-2-171 | 66 | 45 | 60 | 51 | 72 | 27 | 57 |
23 | DJY-2-174 | 60 | 99 | 72 | 61 | 64 | 43 | 70 |
24 | DJY-2-170 | 64 | 100 | 62 | 53 | 58 | 36 | 61 |
25 | DJY-2-178 | 50 | 88 | 62 | 40 | 31 | 28 | 48 |
26 | DJY-2-180 | 72 | 44 | 59 | 34 | 65 | 38 | 56 |
27 | DJY-2-179 | 35 | 36 | 56 | 46 | 43 | 21 | 25 |
28 | DJY-2-181 | 37 | 48 | 55 | 39 | 38 | 23 | 53 |
29 | DJY-2-192 | 70 | 66 | 46 | 67 | 70 | 74 | 76 |
30 | DJY-2-197 | 64 | 53 | 61 | 48 | 59 | 24 | 59 |
31 | DJY-2-194 | 75 | 61 | 59 | 52 | 58 | 23 | 73 |
32 | DJY-2-184 | 61 | 87 | 64 | 56 | 61 | 26 | 37 |
33 | DJY-2-176 | 72 | 99 | 63 | 52 | 53 | 25 | 54 |
34 | DJY-2-199 | 37 | 57 | 32 | 50 | 38 | 31 | 22 |
35 | DJY-2-200 | 79 | 84 | 61 | 62 | 61 | 48 | 42 |
36 | DJY-2-127 | 65 | 34 | 74 | 58 | 62 | 59 | 32 |
37 | Psoralen | 56 | 50 | 65 | 63 | 44 | 52 | 58 |
38 | YZK-C22 | 58 | 72 | 74 | 75 | 57 | 81 | 61 |
A.s: tomato early blight, its latin name is: alternaria solani, b.c: the cucumber botrytis cinerea with the latin name as follows: botrytis cinerea, C.a: peanut brown spot pathogen, its latin name is: cercospora arachidicola, G.z: wheat scab, its latin name is: gibberella zeae, P.p: apple ring rot, its latin name is: physiosporia piricola, P.s: rhizoctonia solani, the Latin name of which is: pellicularia sasakii, S.s: sclerotinia sclerotiorum, its latin name is: sclerotina sclerotomalis.
Claims (7)
1. A1, 3, 4-oxadiazole psoralen derivative is characterized by simultaneously containing 1,3, 4-oxadiazole and psoralen structures and has a structural general formula shown in a formula I:
wherein R is1Selected from: hydrogen, 4-fluoro; r2Selected from: 4-methylbenzyl, 4-fluorobenzyl, 3-methylbenzyl, 4-nitrobenzyl, o-methylbenzyl, 4-chlorobenzyl, propargyl, 4-iodobenzyl, n-propyl, 2-naphthylmethyl, allyl, 2, 4-dichlorobenzyl, 4-tert-butylbenzyl, cyclopropylmethyl, 4-chlorobenzoylmethyl, 2-cyano-5-picolyl, 3-bromobenzyl, (E) -2- (2-methoxy-1- (methoxyimino) -2-oxyethyl) benzyl, (E) -2- (1, 3-dimethoxy-3-oxoprop-1-en-2-yl) benzyl, 3-methylbut-2-enyl, m-ethylbenzyl, n-propylbenzyl, n-2-propylbenzyl, p-ethylbenzyl, p-2-ethylbut-2-enyl, p-methyl-benzyl, p-2-ethylbenzyl, p-butyl-2-ethyl, p-benzyl, p-butyl-2-benzyl, p-methyl-2-benzyl, p-methyl, p-2-o-benzyl, p-methyl-benzyl, p-2-p, Benzoylmethyl, 4-trifluoromethoxybenzyl, 2- (4-chlorophenyl) ethyl.
2. The specific synthetic route and method of the 1,3, 4-oxadiazole psoralen derivative I according to claim 1 are as follows:
the definition of the substituent is as defined in claim 1, and the specific synthetic method comprises the following steps:
A. preparation of compound 3:
putting the compound 1 into a reaction bottle, adding the compound 2, then slowly dropwise adding 98% concentrated sulfuric acid while stirring, and stirring at room temperature; after the reaction is finished, adding a proper amount of methanol, then pouring the methanol into ice water to generate a large amount of white solid, and performing suction filtration and drying to obtain a compound 3;
B. preparation of compound 5:
putting the compound 3 into a reaction bottle, adding a proper amount of anhydrous acetonitrile, then sequentially adding potassium carbonate, potassium iodide and the compound 4 while stirring, and heating and refluxing; after the reaction is finished, removing most of acetonitrile under reduced pressure, adding water and ethyl acetate for extraction, washing an organic phase by using a saturated sodium chloride solution, drying anhydrous sodium sulfate, carrying out suction filtration under reduced pressure, concentrating a filtrate to remove a solvent, and carrying out column chromatography purification to obtain a compound 5;
C. preparation of compound 6:
adding a compound 5 into a reaction bottle, adding a proper amount of isopropanol, slowly dropwise adding 1 mol/L sodium hydroxide solution while stirring, and heating and refluxing; after the reaction is finished, removing most of isopropanol under reduced pressure, adjusting the pH of the system to be 1-2 by using 1 mol/L hydrochloric acid solution, and performing suction filtration and drying on the generated solid to obtain a compound 6;
D. preparation of compound 7:
taking the compound 6, adding a proper amount of anhydrous methanol into a reaction bottle, then slowly dropwise adding 98% concentrated sulfuric acid while stirring, and heating and refluxing; after the reaction is finished, removing most of methanol under reduced pressure, adding water and ethyl acetate into the residue for extraction, washing an organic phase by using a saturated sodium chloride solution, drying the organic phase by using anhydrous sodium sulfate, carrying out suction filtration under reduced pressure, concentrating the filtrate to remove the solvent, and carrying out column chromatography purification to obtain a compound 7;
E. preparation of compound 8:
taking the compound 7, adding a proper amount of methanol into a reaction bottle, slowly dropwise adding 80% hydrazine hydrate while stirring, and heating and refluxing; after the reaction is finished, removing most of methanol under reduced pressure, adding water and ethyl acetate into the residue for extraction, washing an organic phase by using a saturated sodium chloride solution, drying by using anhydrous sodium sulfate, carrying out suction filtration under reduced pressure, concentrating the filtrate to remove the solvent, and carrying out column chromatography purification to obtain a compound 8;
F. preparation of compound 9:
putting the compound 8 into a reaction bottle, adding a proper amount of absolute ethyl alcohol, adding potassium hydroxide under stirring, then slowly dropwise adding carbon disulfide, and heating and refluxing; after the reaction is finished, removing most of ethanol under reduced pressure, adding 1 mol/L hydrochloric acid solution into the residue to adjust the pH of the system to be 1-2, extracting with ethyl acetate, washing an organic phase with saturated sodium chloride solution, drying with anhydrous sodium sulfate, carrying out suction filtration under reduced pressure, concentrating the filtrate to remove the solvent, and purifying by column chromatography to obtain a compound 9;
G. preparation of Compound I-a:
taking the compound 9, adding a proper amount of N, N-dimethylformamide into a reaction bottle, sequentially adding potassium hydroxide, chlorohydrocarbon or bromohydrocarbon, and stirring at room temperature; after the reaction is finished, adding a proper amount of water and ethyl acetate for extraction, washing an organic phase by using a saturated sodium chloride solution, drying by using anhydrous sodium sulfate, carrying out vacuum filtration, concentrating the filtrate to remove the solvent, and carrying out column chromatography purification to obtain a compound I-a;
H. preparation of Compound I-b:
under the condition of low-temperature ice bath, taking the compound I-a, adding a proper amount of dichloromethane into a reaction bottle, then slowly dropwise adding a dichloromethane solution dissolved with m-chloroperoxybenzoic acid, and moving the system to room temperature for stirring; after the reaction is finished, removing most dichloromethane under reduced pressure, adding a proper amount of ethyl acetate into the residue, washing the residue with 0.25 mol/L disodium hydrogen phosphate solution and saturated sodium chloride solution in sequence, drying the solution with anhydrous sodium sulfate, carrying out suction filtration under reduced pressure, concentrating the filtrate to remove the solvent, and carrying out column chromatography purification to obtain a compound I-b;
I. preparation of Compounds I-c:
under the condition of low-temperature ice bath, taking the compound I-a, adding a proper amount of acetic acid into a reaction bottle, slowly dropwise adding a hydrogen peroxide solution dissolved with ammonium molybdate while stirring, and then transferring the system to room temperature for stirring; after the reaction is finished, adding water and ethyl acetate for extraction, washing the organic phase with a saturated sodium bisulfate solution and a saturated sodium chloride solution successively, drying with anhydrous sodium sulfate, carrying out suction filtration under reduced pressure, concentrating the filtrate to remove the solvent, and carrying out column chromatography purification to obtain the compound I-c.
3. Use of the 1,3, 4-oxadiazolidvachalene derivative I as claimed in claim 1 for the preparation of agricultural fungicides.
4. An agricultural fungicidal composition comprising the 1,3, 4-oxadiazolidvachellinoid derivative I according to claim 1 and an intermediate, which can be prepared as an agricultural fungicidal composition comprising the 1,3, 4-oxadiazolidvachellinoid derivative I according to claim 1 as an active ingredient in an amount of 0.1 to 99.9% by weight, 99.9 to 0.1% by weight of a solid or liquid adjuvant and optionally 0 to 25% by weight of a surfactant.
5. An agricultural sterilization compound composition, which comprises 1,3, 4-oxadiazole psoralen derivative I and other commercial bactericides as active ingredients, wherein the mass percentage of the 1,3, 4-oxadiazole psoralen derivative I to the other commercial bactericides is 1 percent to 99 percent to 1 percent, the content of the active ingredients is 1 to 99 percent by weight, and the content of the solid or liquid auxiliary agents is 99 to 1 percent by weight.
6. An agricultural insecticidal and acaricidal compound composition, which comprises 1,3, 4-oxadiazole psoralen derivative I and other commercial insecticidal and acaricidal agents as active ingredients, wherein the mass percentage of the 1,3, 4-oxadiazole psoralen derivative I to the other commercial insecticidal and acaricidal agents is 1% to 99% to 1%, the content of the active ingredients is 1 to 99% by weight, and the content of the solid or liquid auxiliary agents is 99 to 1% by weight.
7. An anti-plant virus agent compound composition, which comprises 1,3, 4-oxadiazole psoralen derivative I and other commercial anti-plant virus agents of claim 1 as active ingredients, wherein the mass percentage of the 1,3, 4-oxadiazole psoralen derivative I and the other commercial anti-plant virus agents is 1% to 99% to 1%, the content of the active ingredients is 1 to 99% by weight, and the weight of the active ingredients is 99 to 1% by weight of solid or liquid auxiliary agents.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111351143.3A CN113929697B (en) | 2021-11-16 | 1,3, 4-Oxadiazole psoralen derivatives, and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111351143.3A CN113929697B (en) | 2021-11-16 | 1,3, 4-Oxadiazole psoralen derivatives, and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113929697A true CN113929697A (en) | 2022-01-14 |
CN113929697B CN113929697B (en) | 2024-05-14 |
Family
ID=
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1566114A (en) * | 2003-06-16 | 2005-01-19 | 高和英 | Novel psoralen derivative for annihilating live virus or germ |
US20090155224A1 (en) * | 2007-06-28 | 2009-06-18 | Laskin Jeffrey D | Dimethyl amino ethyl ether psoralens and methods for their production and use |
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1566114A (en) * | 2003-06-16 | 2005-01-19 | 高和英 | Novel psoralen derivative for annihilating live virus or germ |
US20090155224A1 (en) * | 2007-06-28 | 2009-06-18 | Laskin Jeffrey D | Dimethyl amino ethyl ether psoralens and methods for their production and use |
Non-Patent Citations (1)
Title |
---|
FARAG, NAHLA A. H. 等: "Design, synthesis and docking studies of new furobenzopyranones and pyranobenzopyranones as photoreagent towards DNA and as antimicrobial agents", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 45, no. 01, pages 317 - 325, XP026808501 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104650062A (en) | Nitrogen heterocyclic ring thiazole derivative, preparation method and applications thereof | |
CN105622597A (en) | Chloroisothiazole neonicotine compound, as well as preparation method and application thereof | |
CN104649996A (en) | Isothiazole oxime ether derivatives as well as preparation method and application thereof | |
CN112939980A (en) | 3, 4-dichloroisothiazole heterocyclic purine derivatives and preparation method and application thereof | |
CN110041260A (en) | A kind of multi-substituted pyrazol amide derivatives and its preparation method and application | |
CN109422704A (en) | A kind of 4 substituted thiazole amide derivatives and its preparation method and application | |
CN109485618A (en) | A kind of 2 phenylsubstituted thiazoles derivatives and its preparation method and application | |
CN113929695A (en) | Sulfenimide psoralen derivatives, and preparation method and application thereof | |
CN107226812A (en) | One class piperidines thiazole oxime ether methoxy base acrylate derivative and its production and use | |
CN113880863A (en) | 1,2, 4-triazole [3,4-b ] -1,3, 4-thiadiazine derivatives and preparation method and application thereof | |
CN103641795B (en) | One class contains acetophenone derivs of 1,2,3-thiadiazoles and its production and use | |
CN112358474A (en) | Difluoropyrazole thiazole methanamide derivatives and preparation method and application thereof | |
CN103483288B (en) | One class 3,4-bis-chloroisothiazole bishydrazide compounds and its production and use | |
CN112480103A (en) | Coumarin derivatives containing 3, 4-dichloroisothiazole and preparation method and application thereof | |
CN113929697B (en) | 1,3, 4-Oxadiazole psoralen derivatives, and preparation method and application thereof | |
CN113929697A (en) | 1,3, 4-oxadiazole psoralen derivatives and preparation method and application thereof | |
CN105503708B (en) | The heterocyclic compound of one kind containing bis-fluoro ethyls and its preparation method and application | |
CN107602547A (en) | Heterocycle triazole derivative and its production and use | |
CN102633746A (en) | Di-hydrazide derivatives containing 5-methyl-1, 2, 3-thiadizole and preparation method and application of di-hydrazide derivatives containing 5-methyl-1, 2, 3-thiadizole | |
CN113929696B (en) | Acyl thiourea psoralen derivatives, and preparation method and application thereof | |
CN113929694A (en) | Sulfonyl hydrazide psoralen derivatives, and preparation method and application thereof | |
CN113929696A (en) | Acylthiourea psoralen derivatives, and preparation method and application thereof | |
CN106995420B (en) | A kind of thiadiazoles oxime ether methoxy base acrylate derivative and its preparation method and application | |
CN107459514B (en) | Chiral piperidine derivative and preparation method and application thereof | |
CN104447617A (en) | Synthesis and application of nitro arylideneamino guanidine compounds containing 1, 2, 3-thiadiazole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant |